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Abstract
Research Questions
Is there a gender susceptibility to congenital diaphragmatic hernia in the nitrofen rat 
model and is it associated with disordered sexual development?
Background
Congenital diaphragmatic hernia is a frequently fatal birth defect, mostly due to 
associated pulmonary problems, affecting 1 in 3000 live births. About 40% of cases 
have associated anomalies of which 20% affect the sexual phenotype. Human 
cases note sex reversal syndromes, ambiguous genitalia and maldevelopment of 
genitalia accompanying congenital diaphragmatic hernia. Human studies have also 
noted sex difference (s) in the incidence of congenital diaphragmatic hernia but the 
reports are ambiguous, some epidemiology surveys recording a higher incidence of 
congenital diaphragmatic hernia in females, whilst other reports cite a higher 
frequency in males. Nitrofen, a teratogenic substance, produces experimental 
congenital diaphragmatic hernia in rodents. Nitrofen is speculated to interfere with 
retinoic acid - steroid signalling pathways and these may also be linked with sexual 
differentiation. Development of the diaphragm and lungs has been studied using 
animal models. This study was designed to test the hypothesis that nitrofen may 
influence sexual phenotype and gender frequency of congenital diaphragmatic 
hernia in a well characterised animal model of this condition.
Methods
Time mated Sprague Dawiey rats were gavage fed nitrofen at day 9.5 to generate 
predominantly left sided congenital diaphragmatic hernia. Fetuses were delivered by 
caesarean section on days 20 or 21 of gestation (term = day 22). External genitalia 
were examined to define external genital phenotype. The abdominal cavity was 
opened and the genito-urinary system examined. The internal genital organs were 
assigned a phenotype and findings correlated with external appearances. The 
diaphragm of each fetus was studied for the absence or presence of congenital 
diaphragmatic hernia and the laterality of the defect recorded. Controls (non nitrofen 
fed) were used for all comparative analysis.
Results
Control (n = 600) and nitrofen exposed offspring (n = 518) had equal frequencies of 
males and females. There was no significant difference in the frequency of 
congenital diaphragmatic hernia occurring in male and female nitrofen treated pups. 
In all nitrofen exposed fetuses and normal controls, internal and external genitalia 
concorded without evidence of significant genital tract malformations or intersex 
states.
Conclusions
Prenatal nitrofen exposure is not associated with significant gender differences (or 
prenatal loss) in the risk of congenital diaphragmatic hernia. Genital tract 
malformations do not appear to accompany congenital diaphragmatic hernia in the 
nitrofen rat model.
Key Words
Sexual phenotype, congenital diaphragmatic hernia, nitrofen,
15
Acknowledgements
I would first like to thank Dr. Audrey Smith for first arousing my interest in congenital 
anomalies, initially congenital heart disease and for her enduring friendship and 
support.
I would like to thank Dr. Mark Jackson and Mr. Dakshesh Parikh for introducing me 
to the embryology, both morphological and molecular of congenital anomalies and 
this has been the mainstay of all my work since.
I would like to thank Professor David Lloyd for later inviting me to join the Pediatric 
Surgery research team where 1 enjoyed my time working with the surgical fellows 
who passed through the department studying for their further degrees.
I would like to particularly thank Professor Paul Losty for introducing me to the 
nitrofen model of congenital diaphragmatic hernia, the subject that has fascinated 
me for my entire working life afterwards.
I would like to thank Mr. Edwin Jesudason for his input and encouragement as I 
worked on the Nitrofen model of congenital diaphragmatic hernia and lung 
development.
I would like to thank Ms. Kerry Dwan for her statistically advice.
I would like to thank my friends and colleagues who were always there with a 
cheery smile and a cup of tea when research was not going well and I was feeling 
down.
Finally I would like to thank Dr. Kevin Southern and Dr. Helen Wallace for the 
support and encouragement to complete this thesis.
16
CHAPTER 1
Introduction, the Development of the Diaphragm, Lung and 
Reproductive System
1.1 Congenital Diaphragmatic Hernia
1.1.1 Background
Congenital diaphragmatic hernia is a developmental defect resulting in disordered 
diaphragmatic growth in the embryo causing an abnormality in the integrity of the 
diaphragm.
Congenital diaphragmatic hernia is a frequently fatal birth defect affecting 1 in 3000 
live births.
1.1.2 Features and Definition of Congenital Diaphragmatic Hernia 
1.1.2.1 Definition of Congenital Diaphragmatic Hernia
The diaphragm is a muscular structure that separates the abdominal cavity from the 
thoracic cavity and this maintains the pressure differentials between the two 
cavities. Contraction of the diaphragm contributes to ventilation. Congenital 
diaphragmatic hernia forms a spectrum of birth defects characterised by incomplete 
formation of the diaphragm allowing a communication between the thoracic and 
abdominal cavities. Also in this spectrum is a thinning of the diaphragm, known as 
an eventration. This is the result of incomplete muscularisation of the diaphragm 
resulting in the elevation of the thinned portion of the diaphragm. Congenital 
diaphragmatic hernia can be classified as isolated or complex. Isolated congenital 
diaphragmatic hernia is diagnosed when the hernia is the only apparent major 
malformation. Pulmonary hypoplasia and pulmonary hypertension, intestinal rotation 
and left heart hypoplasia due to compression are considered to be part of the 
primary anomaly sequence (Pober 2007).
Complex congenital diaphragmatic hernia is diagnosed when additional 
abnormalities occur either as part of a recognised syndrome, a chromosomal 
abnormality or with accompanying major anomalies of other organs that do not form 
part of a recognised syndrome (Pober 2007). The frequency of complex congenital 
diaphragmatic hernia ranges from as low as 10% to as high as 50% which could be
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due to the difference in the methods of data coliection (Skari, Bjornland et ai. 2000). 
Other more recent studies classify approximately 40% of cases as complex (Torfs, 
Curry et al. 1992; Dott, Wong et ai. 2003; Colvin, Bower et al. 2005).
1.1.2.2 Types of Congenital Diaphragmatic Hernia
The most common type of hernia is the posterolateral, Bochdalek hernia. These 
form about 80% to 90% of all cases of congenital diaphragmatic hernia. 85% of 
posterolateral hernia cases are on the left side, 10% are right sided and 5% are 
bilateral. Congenital diaphragmatic hernia is often accompanied by herniation of the 
abdominal organs into the chest cavity.
Apparent absence or an extremely large hernia of the diaphragm is termed 
agenesis but this defect probably represents the severe end of the Bochdalek 
hernia spectrum and is not likely to be a distinct entity. These hernias can be 
associated with absent or extremely deficient rim of posterior and lateral muscle or 
have a complete rim of the muscle (Pober, Russell et al. 1993).
A less common defect is the Morgagni hernia, an anterior hernia. This type 
comprises approximately 2% of all congenital diaphragmatic hernia cases and is 
generally associated with a hernia sac. These hernias may be undetected in the 
newborn as they may be asymptomatic. Other rare hernias include central hernias 
and rare anterior types of hernia. Anterior hernias tend to be severe and are found 
in individuals with associated midline anomalies, termed the Pentalogy of Cantrell 
(Cantrell, Haller et al. 1958; Milne, Morosin et al. 1990)
It is difficult to estimate the frequency of eventration because it may coexist with 
and/or be misdiagnosed as a Bochdalek hernia. Severe diaphragmatic eventration 
is associated with pulmonary hypoplasia and respiratory distress during infancy. 
Milder degrees of diaphragmatic eventration can present later in life with respiratory 
symptoms such as cough and pneumonias, or without symptoms so that the 
diagnosis is made incidentally on chest x-ray. It has been observed that eventration 
of the diaphragm and "true" congenital diaphragmatic hernia can occur in the same 
individual, suggesting that they may share a common aetiology (Mertins 1952; 
Thomas, Stern et al. 1976; Rodgers and Hawks 1986).
The following diagrams show a normal diaphragm and the different types of hernia 
from an overview by Barbara J Pober (Pober, Russell et al. 1993) updated 2010.
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Figure 1 Normal Diaphragm
The following figures show diaphragms as seen from below from an overview 
by Barbara J Pober (Pober, Russell et al. 1993) updated 2010 as shown in 
diagram A. Diagram B shows a normal diaphragm
Anterior
Normal diaphragm
(for reference)
Note: Views in figures are from below.
(*) Posterior
Xyphoid
Attachment of 
falciform ligament
Central tendon 
Inferior vena cava
Esophagus
Muscular crurae 
surrounding esophagus
(L)
Figure 2 Different types of congenital diaphragmatic hernias
Diagrams showing different types of congenital diaphragmatic hernia. 
Diagram A demonstrates the posterior position of the Bochdalek hernia. 
Diagram B shows the position of a Morgagni hernia and other anterior 
hernias. Diagram C shows the position of a central hernia
Bochdalek hernia Morgnani hernia and other anterior hernias Central hernia
1.1.2.3 Incidence of Congenital Diaphragmatic Hernia
Congenital diaphragmatic hernia is identified in approximately 1 in 3000 live births 
but the true incidence of this defect is difficult to ascertain because:-
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1 It is difficult to establish how many pregnancies are lost due to congenital 
diaphragmatic hernia prior to term (Harrison, Adzick et al. 1994; Skari, Bjorniand et 
al. 1998).
2 Also newborns with congenital diaphragmatic hernia may die prior to transfer 
to units that collect data for this disease (Harrison, Bjordal et al. 1978; Jaffray and 
MacKinlay 1996).
3 Cases of congenital diaphragmatic hernia that present outside the neonatal 
period may never be included in the estimates of frequency (McCue, Ball et al. 
1985; Berman, Stringer et al. 1988; Berman, Stringer et al. 1988).
4 The facilities for collecting accurate details of all live and still births may vary 
from country to country.
Given these caveats the frequency estimation can only be an approximation.
1.1.2.4 Epidemiology
Robert and colleagues collected data from 1973 until 1993 on postero-lateral 
congenital diaphragmatic hernia. These data were from three population based 
studies looking at the epidemiology of birth defects. This study did not include 
induced or spontaneous abortions, but included all infants born and still births from 
28 weeks. The total number of births included in this study was 5,971,525 which 
were from France, Sweden and California. The study was based on a total of 1439 
cases of congenital diaphragmatic hernia of which 875 cases were isolated hernias, 
486 had associated malformations with no recognised chromosomal anomalies and 
78 with chromosomal anomalies. Maternal age had no significant effect. Right sided 
congenital diaphragmatic was found in 20% of unilateral cases in both isolated and 
complex cases and there was no difference in the sex ratio (Robert, Kallen et al. 
1997) as had been previously suggested (Benjamin, Juul et al. 1988). Bilateral 
cases of congenital diaphragmatic hernia were found more frequently in the 
complex cases than in the isolated cases. The risk of congenital diaphragmatic 
hernia was significantly increased in the case of twinning (Torfs, Curry et al. 1992). 
There was no evidence for geographical or racial variations in the frequency of 
congenital diaphragmatic hernia (Robert, Kallen et al. 1997; Yang, Carmichael et al. 
2006).
Using the National Birth Defects Prevention study and a telephone interview for 
births between 1989 and 1997, Yang and colleagues surmised that maternal uptake
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of nutrients and vitamins in the year before pregnancy reduced the incidence of 
congenital diaphragmatic hernia, and that in many cases this may be involved with 
the retinoid signalling pathway. This was a substantial study with 377 cases of 
mothers of babies born with congenital diaphragmatic hernia and 5008 control 
mothers (Yang, Shaw et al. 2008).
The Eurocat statistaticaf monitoring of trends of congenital anomalies in Europe 
reported a 4% decreasing incidence in the frequency of congenital diaphragmatic 
hernia (Loane, Dolk et al. 2011).
1.1.2.5 Impact of Gender on Incidence
Birth registries and epidemiology surveys record conflicting data on gender and 
congenital diaphragmatic hernia. Slightly more males are born than females; this 
has long been documented but remains unexplained. The ratio of males to females 
is approximately 1.06-1.04 with small fluctuations (Ohmi, Hirooka et al. 1999) 
obtained from the statistics of pregnancy and childbirth from the London Stationary 
office.
In a subset of newborns with congenital anomalies some are much more prevalent 
in males, such as certain heart defects, transposition of the great arteries or 
hypoplastic left heart (Botto, Correa et al. 2001; Harris, Francannet et al. 2003; 
Pradat, Francannet et al. 2003; Shaw, Carmichael et al. 2003) with up to two out of 
every three cases being male. For spina bifida and anencephaly there is a female 
excess (Bamforth and Baird 1989; Kallen, Cocchi et al. 1994). This sex related 
susceptibility could be related to a sex specific sensitivity to environmental 
teratogens or sex specific survival during pregnancy (Lisi, Botto et al. 2005).
David and colleagues reported in 1976 a higher proportion of females with 
congenital diaphragmatic hernia from cases between 1943 and 1974, 81 female and 
62 male. This study included all cases of congenital diaphragmatic hernia born in 
Bristol, UK, during this time and includes cases of eventration of the diaphragm and 
stillbirths (David and Illingworth 1976) but the numbers from this study were small, 
in a later study from Avon a further 26 cases were added to this study, collected by 
the same methods giving sex totals of 90 females and 79 males (David, Parker et 
al. 1980), but these later figures included a higher proportion of males with 
congenital diaphragmatic hernia but this was still a small number of total cases.
A study reported in 2005 including 18 registries from 24 countries reported a higher 
incidence in males with a ratio of 1.42 to 1.0; the numbers involved being 1,730
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males and 1,219 females with congenital diaphragmatic hernia. This study also 
reported that as well as defects of the diaphragm, defects of the abdominal wall are 
also more frequent in males (Lisi, Botto et al. 2005).
The California birth defects registry reported by Robert and colleagues found a 
change in distribution in the gender prevalence of complex congenital diaphragmatic 
hernia from 1988 onwards. This was a shift to a higher prevalence in males in cases 
of complex congenital diaphragmatic hernia that was statistically significant but the 
reasons for this have not yet been explained (Robert, Kallen et al. 1997). This same 
study found a higher incidence of congenital diaphragmatic hernia in males in 
studies from France and Sweden, also as reported previously (Robert, Kallen et al. 
1997).
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1.2 The Normal Embryonic Development of the Diaphragm
1.2.1 Morphological Development of the Diaphragm.
The human diaphragm develops between the 4th and 12th week of gestation and in 
the mouse between 10.5 and 15.5 days post coitum (dpc). The gestation period in 
the mouse is 18.5 days. The tissues that contribute to the muscular diaphragm 
development are referred to as the pleuroperitoneal folds and the post hepatic 
mesenchymal plate tissue. These structures may be different sections of the same 
mesodermal tissue and the terms are used interchangeably by different 
investigators to describe tissue contributions to the diaphragm (Greer, Allan et al. 
2000; Ackerman and Greer 2007). The pleuroperitoneal folds are paired pyramidal 
shaped structures most evident in the embryonic thorax just before the formation of 
the diaphragm at the level of the forelimb, 11,5dpc in the mouse 13.5dpc in the rat 
and 4-6 weeks in the human. The diaphragm is formed by the closure of the 
pleuroperitoneal fold, occurring at 12.5dpc in mice, to form the membranous 
scaffold of the diaphragm (Babiuk, Zhang et al. 2003), a mesenchymal substratum 
that is derived from the somatopleure (Tosney 1988). This creates a continuous 
sheet that completely separates the abdominal and thoracic cavities. The muscular 
component of the diaphragm forms on this substratum (Babiuk, Zhang et al. 2003). 
In mice with a mutation (c-met null micej that prevents muscle precursors from 
migrating to the peripheral muscles including the pleuroperitoneal fold thus 
preventing the muscularisation the diaphragm the membranous scaffold of the 
diaphragm is complete (Babiuk and Greer 2002).
It was the traditional view that the diaphragm developed from four different 
structures, the central portion of the diaphragm came from the septum transversum, 
the posterolateral section from the pleuroperitoneal folds, the portion of the 
diaphragm posterior to the oesophagus came from the oesophageal mesentery and 
a rim of musculature around the periphery of the diaphragm arose from elements of 
the thoracic body wall.
Defects in the diaphragm of multiple animal models of congenital diaphragmatic 
hernia are shown to originate from abnormal pleuroperitoneal fold development 
(Clugston, Klattig et al. 2006; Clugston, Zhang et al. 2010).
The study of rodent diaphragm development has failed to identify contribution from 
the elements traditionally considered to be involved in human diaphragmatic 
development, apart from the pleuroperitoneal fold which contributes myogenic cells
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and axons which expand to form the neuromuscular component of the diaphragm 
(Babiuk, Zhang et al. 2003). If this model is also applicable to diaphragm 
development in humans then the traditional view of diaphragmatic development 
needs revising (Clugston, Klattig et al. 2006).
1.2.1.1 The Pleuroperitoneal Fold
The pleuroperitoneal fold in human embryos was observed to have the same 
pyramidal structure, triangular cross section and anatomic location as the 
pleuroperitoneal fold seen in animal models. The observation that abnormal 
pleuroperitoneal fold development underlies diaphragm defects in numerous animal 
models has lead to the hypothesis that a defect in the human pleuroperitoneal fold 
leads to diaphragmatic maldevelopment in humans (Clugston, Klattig et al. 2006). If 
this were to be the case, the critical time for congenital diaphragmatic hernia 
development would be between four and six weeks gestation, before the pregnancy 
has been positively confirmed (Torfs, Curry et al. 1992).
Myogenic cells, the diaphragmatic muscle precursor cells, and phrenic axons 
migrate to the pleuroperitoneal fold reaching the pleuroperitoneal fold by 12.5dpc in 
the rat (Babiuk, Zhang et al. 2003) where they begin to differentiate and proliferate. 
From 13.5dpc in the rat muscle precursor cells radiate across the mesenchymal 
substratum from the pleuroperitoneal fold migrating and differentiating towards the 
dorsolateral costal, sterna-costal, and crural regions of the developing diaphragm. 
By 17dpc in the rat they will have spread to all the regions of the diaphragm that are 
destined to be muscularised (Babiuk, Zhang et al. 2003).
This development of the mesenchymal substratum is not well understood but there 
is evidence to suggest that the mesenchymal substratum is derived from the 
somatopleure (Tosney 1988). The mesenchymal substratum forms a continuous 
sheet that completely separates the thoracic and abdominal cavities and it may be a 
separate anatomical entity in itself (Babiuk, Zhang et al. 2003). it appears that the 
muscle forms on top of the mesenchymal substratum leaving the central portion, the 
central tendon, amuscular. Babiuk and colleagues found no contribution to the 
diaphragm musculature from the body wall and other areas as was previously 
described (Babiuk, Zhang et al. 2003). The identity of the guidance cues directing 
the migration and differentiation of these muscle cells destined to populate the 
diaphragm muscle layer is largely unknown, the embryology of this aspect of 
diaphragmatic development being not completely understood (Babiuk, Zhang et al. 
2003).
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The phrenic axons from the brachial plexus migrate towards the pleuroperitoneal 
fold after the muscle precursor cells. Once the phrenic axons reach the 
pleuroperitoneal fold they extend to the same three axis of the diaphragm as the 
muscle precursors, lagging slightly behind the muscle precursors. The muscle 
precursors may be providing guidance cues to these phrenic axons (Allan and 
Greer 1997; Allan and Greer 1998).
Congenital diaphragmatic hernia can form in the absence of lung tissue, the 
embryological origin of the defect is hypothesised to originate from a failure of the 
mesenchymal substratum to form properly (Babiuk and Greer 2002; Clugston, 
Klattig et al. 2006; Clugston, Zhang et al. 2010). The presence of a thickening of 
muscle fibres around the diaphragmatic hernia is consistent with the hypothesis that 
the number of migrating muscle precursor cells is not reduced. Those muscle 
precursor cells destined to populate the area of the defect migrate round the defect 
and differentiate causing the thickened muscular rim (Allan and Greer 1997; Gallot, 
Marceau et al. 2005). This thickening surrounding the defect has also been 
identified in human cases of congenital diaphragmatic hernia at post mortem and on 
magnetic resonance imaging on infants surviving the perinatal period (Clugston, 
Klattig et al. 2006).
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1.2.2 Transcription Factors and Pathways Implicated in Diaphragm 
Development
1.2.2.1 Retinoic Acid Signalling Pathway
Retinoic acid is a small lipophilic molecule derived from Vitamin A. Unlike protein 
factors such as the fibroblast growth factors or the transforming growth factors that 
bind to cell surface receptors and initiate cell signalling pathways, retinoic acid 
enters the cell nucleus and directly binds to target genes via nuclear receptors 
(Duester 2008). The first connection between retinoids, diaphragm development 
and congenital diaphragmatic hernia resulted from the observation that rats fed a 
diet deficient in vitamin A had offspring with a 25% to 40% incidence of congenital 
diaphragmatic hernia. The incidence of congenital diaphragmatic hernia in these 
offspring reduced if vitamin A was reintroduced into the diet mid-gestation (Warkany 
and Schraffenberger 1946; Wilson, Roth et al. 1953).
The conversion of retinoic acid from vitamin A is an enzymatic conversion of the 
alcohol form of vitamin A (retinol) to an aldehyde (retinaldehyde) and then to a 
carboxylic acid (retinoic acid). This conversion is catalysed by several alcohol 
dehydrogenases and retinol dehydrogenases whose expression is widespread and 
overlapping (Ang, Deltour et al. 1996; Zhang, Chen et al. 2001; Sandell, Sanderson 
et al. 2007). The developing diaphragm expresses proteins associated with retinoids 
(Bavik, Ward et al. 1997; Mey, Babiuk et al. 2003). Retinoic acid receptor a and (3 
double null mutant mice have congenital diaphragmatic hernias similar to those 
observed after nitrofen exposure (Mendelsohn, Lohnes et al. 1994; Lohnes, Mark et 
al. 1995).
The concentration of dietary vitamin A must be within a very narrow range to avoid 
either toxicity or deficiency. Early studies indicated that retinoic acid was essential 
for the embryological development of several organs including the hindbrain, spinal 
cord, heart, forelimb buds, lung, pancreas, diaphragm and genitourinary tract 
(Dersch and Zile 1993; Lohnes, Mark et al. 1994; Mendelsohn, Lohnes et al. 1994; 
Dickman, Thaller et al. 1997; Clagett-Dame and DeLuca 2002). In a small hospital 
based study human infants with congenital diaphragmatic hernia were 
demonstrated to have reduced levels of retinol and of retinol binding protein 
compared to infants without anomalies (Major, Cadenas et al. 1998). Maternal 
retinol and retinol binding protein status was no different between the mothers of 
affected or normal infants in a later study (Beurskens, Tibboel et al. 2010). This
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study demonstrates that a perturbation of retinoid signalling and congenital 
diaphragmatic hernia observed in animal models is also implicated in the 
pathogenesis of human congenital diaphragmatic hernia (Beurskens, Tibboel et al. 
2010).
Goumy and colleagues proposed that Stimulated by retinoic acid gene 6 homolog 
(STRA6), Lecithin retinol acyltransferase (LRAT), Cellular retinol binding protein-1 
{CRBP1), Cellular retinol binding protein-2 CRBP2 and Cellular retinoic acid binding 
protein-1 (CRABP1) are directly implicated in retinoic acid metabolism and are 
potential candidate genes for cases of congenital diaphragmatic hernia detailed 
below. There has been a total of more than twenty retinoic acid pathway genes 
proposed, including the well studied COUP-TF11, FOG2 and GATA4 detailed 
below. They are implicated in diaphragmatic development and are given in more 
detail later (Gremeau, Coste et al. 2009; Goumy, Gouas et al. 2010).
Stimulated by retinoic acid gene 6 homolog (STRA6) is the receptor for retinol 
binding protein and is responsible for the transport of retinol to specific sites 
(Kawaguchi, Yu et al. 2007). Mutations in STRA6 are associated with Matthew- 
Wood syndrome (Golzio, Martinovic-Bouriel et al. 2007; Pasutto, Sticht et al. 2007).
Lecithin retinol acyltransferase (LRAT) is an enzyme that catalyses the esterification 
of all-trans-retinol into all-trans retinyl ester for storage in the cytoplasm (Ruiz, 
Winston et al. 1999).
Cellular retinol binding proteins 1 and 2 (CRPB1 and CRPB2) are the carrier 
proteins involved in the transport of retinol (Herr and Ong 1992; Noy 2000).
Cellular retinoic acid binding protein 1 (CRAPB1) assists the entry of retinoic acid 
into the nucleus. Retinoic acid binds to the nuclear retinoic acid receptor (RAR) and 
retinoid X receptor (RXR), and this binding activates the transcription of many target 
genes (Goumy, Gouas et al. 2010).
Chicken ovalbumin upstream promoter factor 11 (COUP-TF11) inhibits the retinoic 
acid pathway by affecting the RAR/RXR heterodimer, inhibiting gene expression. 
COUPTF-11 interacts with friend of GATA2 (FOG2) modulating the activity of 
GATA4 proteins a transcription factor that has an important role in the embryological 
development of many organs (Goumy, Gouas et al. 2010).
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Figure 3 Retinoic acid pathway
The alcoholic form of Vitamin A, retinol is carried in the plasma by retinol 
binding protein (RBP). Retinol enters the cell via a specific receptor, 
Stimulated by retinoic acid gene 6 homolog (STRA6) which is responsible for 
the transport of retinol to specific sites. In the cell cytoplasm retinol may be 
converted to retinyl esters for storage facilitated by cellular retinol binding 
protein (CRPB) or oxidised to retinaldehyde by either alcohol dehydrogenase 
(ADH) or retinol dehydrogenase (RDM). Retinaldehyde is oxidised to retinoic 
acid (RA) by retinaldehyde dehydrogenase (RALDH). In cells that are not RA 
target cells RA is degraded by CYP26 to hydroxy RA and excreted. RA target 
cells express cellular retinoic acid binding protein 1 (CRABP1) that transports 
the RA into the cell nucleus. In the nucleus RA binds with the retinoid X 
receptor (RXR) and the retinoic acid receptor (RAR) heterodimer regulating 
the transcription of RA target genes. This transcription is modulated by 
chicken ovalbumin upstream promoter factor 11 (COUPTF11) by repressing 
RXR thereby inhibiting the RAR/RXR heterodimer. COUPTF11 interacts with 
FOG2 modulating the transcriptional activity of GATA4 proteins which plays 
an important role in early embryogenesis
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1.2.2.2 Paired box 3 (PAX3) Formally Known as Splotch
Paired box 3 (pax3) deficient splotch mice display an array of neural crest related 
abnormalities including congenital heart disease. Transgenic Splotch mice have an 
absence of a muscular diaphragm, having only a thin fibrous membrane which 
prevented the abdominal organs from entering the thorax (Li, Liu et al. 1999). Pax3 
is expressed in the muscle precursor cells in the pleuroperitoneal fold.
1.2.2.3 Friend of GATA Binding Protein 2, (FOG2)
GATA binding protein transcription factors are a family of transcription factors 
characterised by their ability to bind to the DNA sequence GATA (Ko and Engel 
1993). Friend of GATA2 (FOG2) is a transcription cofactor for the GATA family of 
transcription factors. The interactions of fog2 with GATA4 in vivo are necessary for 
normal lung, diaphragm, cardiac and gonadal development (Crispino, Lodish et al. 
1999; Tevosian, Albrecht et al. 2002; Ackerman, Wang et al. 2007; Jay, Bielinska et 
al. 2007). Fog2 is a zinc finger transcription factor and these are small protein 
structural motifs that include one or more zinc ions to help stabilise their folds. 
FOG2 is the first gene implicated in the pathogenesis of non-syndromic congenital 
diaphragmatic hernia (Ackerman, Herron et al. 2005), and the first gene recognised 
to be necessary for the primary development of both lung and diaphragm. Fog2 is 
expressed in the pleuroperitoneal tissue and mice carrying a homozygote 
hypomorphic mutation in fog2 have abnormal patterns of muscularisation and no 
delineated central tendon. These mice may survive until late gestation (Ackerman, 
Herron et al. 2005) but fog2 null mice die from cardiac defects before diaphragm 
development (Tevosian, Deconinck et al. 2000).
A fog2 mutation was created in mice by Ackerman and colleagues (Ackerman, 
Herron et al. 2005) that displayed pulmonary hypoplasia and a thin diaphragm. They 
called the mutation little lung (7/7). Diaphragms from the HI mice have a defect in the 
muscular patterning of the diaphragm similar to mice with defects in hepatocyte 
growth factor expression, which is a candidate factor responsible for the guidance of 
the muscle precursor cells (Dietrich, Abou-Rebyeh et al. 1999). Fog2 does not 
colocalise with pax3, as it is expressed in the mesenchyme of the pleuroperitoneal 
fold, and pax3 is expressed in the muscle precursor cells. Fog2 does however 
colocalise with GATA4 (Clugston, Zhang et al. 2008) Both fog2 and GATA4 
expression has been observed in the nuclei of cells throughout the pleuroperitoneal 
fold of rat embryos at 13.5dpc. This pattern resembles that previously observed in 
mice (Ackerman and Greer 2007). GATA4 is a member of the zinc finger
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transcription factors and regulates genes involved in embryogenesis and myocardial 
differentiation and function. Mutations of this gene have been associated with 
congenital heart defects and reproductive defects (Crispino, Lodish et al. 2001; 
Tevosian, Albrecht et al. 2002; Ackerman, Wang et al. 2007).
1.2.2.4 GATA Binding Protein 4 (GATA4)
The GATA binding proteins are a family of zinc finger domain containing 
transcription factors which recognise the DNA sequence (A/T)GATA(A/G) in target 
genes (Patient and McGhee 2002). GATA4 co-iocalises with fog2 (Clugston, Zhang 
et al. 2008), and is a transcription factor that interacts with fog2 and this interaction 
is necessary for the development of many organs including the heart, gonads and 
lungs (Crispino, Lodish et al. 2001; Tevosian, Albrecht et al. 2002; Ackerman, Wang 
et al. 2007). 30% of mice heterozygous for a mutant allele of GATA4 have 
herniation of liver through a central diaphragmatic defect (Jay, Bielinska et al. 2007). 
Whether GATA4 mediated diaphragm development is fog2 dependent as in other 
organs is not as yet known, as early embryonic lethality makes the role of these 
factors difficult to establish (Ackerman and Greer 2007). Mutations with GATA4 
have been associated with congenital heart malformations in humans but to date an 
association with human congenital diaphragmatic hernia has not been proved 
(Pober, Russell et al. 1993) updated 2010.
1.2.2.5 Wilms Tumour 1 (WT1)
The Wilms Tumour 1 (WT1) mouse model was developed to study the role of WT1 
in urogenital development and the diaphragmatic defects were an incidental finding 
(Kreidberg, Sariola et al. 1993). WT1 is expressed in the pleuroperitoneal fold of 
humans (Pritchard-Jones, Fleming et al. 1990) and is known to be essential for 
normal diaphragm development (Kreidberg, Sariola et al. 1993; Clugston, Klattig et 
al. 2006). Posterior diaphragmatic defects and other multiple anomalies associated 
with mutations of WT1 and were first reported in 1993 in mice confirming a 
requirement of WT1 for the development of multiple organs (Kreidberg, Sariola et al. 
1993). Clugston and colleagues also reported that the structure of the 
pleuroperitoneal fold in WT1 null mice was found to be abnormal (Clugston, Klattig 
et al. 2006), but early embryonic lethality has prevented detailed analysis of the 
diaphragmatic phenotype.
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1.2.2.6 SlitS
Slit3 is one of the three human homologs of the drosophila Slit gene. During 
embryonic development in mice slits is expressed in the mesothelium of the 
diaphragm (Yuan, Rao et al. 2003). The SlitS knockout mouse models demonstrate 
anterior hernias which extend into the anterior portion of the central tendon; this 
may be due to a defect in the septum transversum (Liu, Zhang et al. 2003; Yuan, 
Rao et al. 2003). This type of congenital diaphragmatic hernia is relatively rare and 
no human cases have been identified with SlitS mutations (Holder, Klaassens et al.
2007) .
1.2.2.7 Chicken Ovalbumin Upstream Promoter Factor 11 (COUP-TF11)
Chicken ovalbumin upstream promoter factor 11 (COUP-TF11) is a member of the 
nuclear receptor super family and essential for normal embryonic development. It is 
a transcription factor in the retinoic acid / thyroid hormone / steroid receptor pathway 
and its expression has been shown to be regulated by retinoids. COUP-TF11 
regulates gene transcription by regulating retinoic acid receptors RAR and RXR 
(Qiu, Krishnan et al. 1996; Shibata, Nawaz et al. 1997; Tsai and Tsai 1997).
In mice coup-tf11 is found in the nuclei of cells throughout the pleuroperitoneal fold 
and in the mesenchyme of the adjacent lung. Coup-tf11 does not co-localise with 
paxS in the pleuroperitoneal fold but does co-localise with WT1 in the mesenchyme 
of the pleuroperitoneal fold (Clugston, Klattig et al. 2006; Clugston, Zhang et al.
2008) . Mouse embryos null for coup-tf11 die before diaphragm formation (Pereira, 
Qiu et al. 1999) but a conditional deletion mouse model has allowed for the 
discovery of a role in posterior diaphragm development (You, Takamoto et al. 
2005). The proteins fog2 and coup-tf11 have been shown interact physically 
(Huggins, Bacani et al. 2001) and it is possible these proteins work together to 
influence the expression of downstream genes important in diaphragm development 
(Scott 2007).
The gene COUP-TF11 is located on chromosome15q26.2 which has recently been 
discovered to be a cytogenetic hotspot for congenital diaphragmatic hernia (Pober 
2007; Pober 2008). COUP TF11 is believed to play a role in human diaphragmatic 
defects associated with multiple birth defects, syndromic congenital diaphragmatic 
hernia.
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1.2.2.8 Basic Helix-Loop-Helix (bHLH)
Numerous basic helix-loop-helix (bHLH) transcription factors have been identified 
which control cell fate, differentiation and morphogenesis during development (Jan 
and Jan 1993; Kadesch 1993). Several bhlh factors are implicated in the 
development of the diaphragm in mice, including capsulin, (also known as pod-1 
and epicardin) which is expressed in the primordial diaphragm and in the 
mesenchymal cells of other developing organs including the lung and testis (Lu, 
Richardson et al. 1998). Capsulin appears to function as a negative regulator of 
differentiation by repressing transcription (Funato, Ohyama et al. 2003). Mice 
homozygous for a capsulin null mutation have pulmonary, cardiac, splenic and renal 
anomalies and male to female sex reversal (Lu, Chang et al. 2000; Cui, Ross et al. 
2004). Mice homozygous for both capsulin and another bhlh factor myoR (myogenic 
repressor) mutation also have congenital diaphragmatic hernia (Lu, Bassel-Duby et 
al. 2002). Mice homozygous for the myogenic differentiation factor 1 {MyoD) 
mutation, another bhlh factor have abnormal muscularisation of the diaphragm 
(Inanlou, Dhillon et al. 2003). MyoR antagonises the actions of myoD. (Lu, Webb et 
al. 1999). No human cases of congenital diaphragmatic hernia have been reported 
with these mutations.
1.2.2.9 Slit2 and Roundabout (ROBO) 1, 3 and 4
Slit2 and Robol are a ligand receptor pair involved in cell migration. Congenital 
diaphragmatic hernia, cardiac and renal defects are associated with Slit deficiency 
in mice (Liu, Zhang et al. 2003). Slit-Robo signalling complex involves heparan 
sulphate (Hussain, Piper et al. 2006). Mutations in the heparan sulphate 
proteoglycan, giypican-3 cause congenital diaphragmatic hernia in humans as does 
duplication of a region of chromosome, which includes ROB03 and ROB04 
(Klaassens, Scott et al. 2006).
1.2.2.10 Glypican-3
Glypican-3 regulates the activities of many growth factors that play a critical role in 
morphogenesis including fibroblast growth factors, bone morphogenic proteins, 
guidance molecules and growth factor antagonists (Paine-Saunders, Viviano et al. 
2000; Paine-Saunders, Viviano et al. 2002; Hussain, Piper et al. 2006). Loss of 
function mutations in the glypican-3 gene causes congenital diaphragmatic hernia, 
facial, skeletal and cardiac abnormalities and a predisposition to embryonal tumours 
including Wilms tumour (Enns, Cox et al. 1998; DeBaun, Ess et al. 2001). Loss of
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function mutations in the gene encoding giypican-3 causes most cases of Simpson- 
Golabi-Behmel syndrome (Pober, Russell et al. 1993; Enns, Cox et al. 1998; 
Slavotinek 2007).
1.2.2.11 Notch
Notch signalling is involved in boundary formation and cell fate by mediating short 
range interactions (Bielinska, Jay et al. 2007). Defects in the Notch signalling 
pathway cause spondylocostal dysostosis, a syndrome with aberrant mesodermal 
patterning. Congenital diaphragmatic hernia is one of the anomalies accompanying 
this syndrome (Lam, Eik-Nes et al. 1999; Sparrow, Clements et al. 2002). Nipped-b 
homolog (NIPBL) is a gene implicated in the Notch signalling pathway and 
mutations of this gene cause Cornelia de Lange syndrome, a developmental 
disorder with genito-urinary anomalies, congenital diaphragmatic hernia and other 
developmental anomalies (Krantz, McCallum et al. 2004).
1.2.2.12 Ephrin-B1
Ephrins play a critical role in cell sorting during a number of developmental 
processes including diaphragmatic development (Davy and Soriano 2005). 
Mutations in the ephrin-B1 gene cause craniofacial syndrome of which congenital 
diaphragmatic hernia is one of the anomalies and although it is an X-linked disorder 
the phenotype is more severe in females (Morris, Palumbos et al. 1987; Vasudevan, 
Twigg et al. 2006). Ephrin-B1 is involved in the process of forming normal tissue 
boundaries (Twigg, Kan et al. 2004; Twigg, Matsumoto et al. 2006).
1.2.2.13 Hepatocyte Growth Factor (HGF)
Hepatocyte growth factor (HGF) is produced in the pleuroperitoneal fold and 
mesenchymal cells including those of the lung, and its tyrosine kinase receptor c- 
Met is expressed in myoblast precursors. In both hgf and c-met null mice the 
diaphragmatic substratum forms normally but due to defects in myoblast migration 
the muscularisation of the diaphragm is impaired (Bladt, Riethmacher et al. 1995; 
Dietrich, Abou-Rebyeh et al. 1999; Sachs, Brohmann et al. 2000). Hgf may be one 
of the target genes for fog2 as fog2 null mice have reduced expression of hgf'm the 
pleuroperitoneal fold. (Ackerman, Herron et al. 2005). In the mouse hgf signalling 
has also been linked to testicular differentiation (Ricci, Catizone et al. 1999) but it is 
unclear if genes encoding HGF or c-Met cause congenital diaphragmatic hernia or 
testicular defects in humans (Bielinska, Jay et al. 2007).
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1.2.3 Extra Cellular Matrix Proteins Involved in Diaphragm 
Development
The extracellular matrix (ECM) includes the interstitial matrix and the basement 
membrane, and is the scaffold providing structural support for the cells, segregating 
tissues from one another, regulating intercellular communication and dynamic 
behaviour. The components of the ECM are mainly secreted by fibroblasts, the 
major component of the ECM scaffold being collagen of which there are many 
isoforms. Glycoproteins such as tenascin, laminin, fibronectin and proteoglycans are 
attached and interwoven with fibrinous proteins such as fibrillins and elastin.
Extra cellular matrix proteins are critical for development and abnormalities in 
several extra cellular proteins have been linked to global abnormalities including 
congenital diaphragmatic hernia and pulmonary complications (Bielinska, Jay et at. 
2007).
1.2.3.1 Elastin
Human mutations in the elastin gene cause congenital diaphragmatic hernia, 
vascular problems, inelastic skin and joint laxity, these are all connective tissue 
defects and mice with homozygous mutations of the elastin gene have similar 
anomalies (Li, Brooke et al. 1998; Wendel, Taylor et al. 2000; Urban, Zhang et al. 
2001; Szabo, Crepeau et al. 2006).
1.2.3.2 Collagen
Ehlers-Danlos syndrome is characterised by abnormal collagen metabolism 
resulting in skin hyper-extensibility, joint laxity, vascular problems and congenital 
diaphragmatic hernia (Abdul Wahab, Janahi et al. 2003; Lin, Ko et al. 2006).
1.2.3.3 Lysil Oxidase
Lysil oxidase is an enzyme that catalyzes the linking of collagen and elastin required 
for the structural integrity of the extra cellular matrix. Lysil oxidase null mice die from 
vascular problems, cardiovascular anomalies and congenital diaphragmatic hernia 
(Maki, Rasanen et al. 2002; Hornstra, Birge et al. 2003; Maki, Sormunen et al. 
2005). No human cases of congenital diaphragmatic hernia have been reported with 
mutations of the lysil oxidase gene. However, a mutation in the human Copper­
transporting ATPase 1 protein encoded by the ATP7A gene (involved in copper 
transport during the biosynthesis of lysil oxidase) causes Menkes disease. Menkes
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disease is a lethal X linked disorder that has congenital diaphragmatic hernia, skin 
and vascular problems amongst its symptoms (Schaefer and Gitlin 1999).
1.2.3.4 Fibulins
Fibulins are proteins that serve to link elastic fibres to the surface of cells (Bielinska, 
Jay et al. 2007). Mutations in the human fibulin genes cause recessive cutis laxa 
with vascular and joint problems, congenital diaphragmatic hernia and emphysema 
(Loeys, Van Maldergem et al. 2002; Hucthagowder, Sausgruber et al. 2006). Mice 
with a mutation in the fibulin genes have a similar phenotype (Yanagisawa, Davis et 
al. 2002; McLaughlin, Chen et al. 2006).
1.2.3.5 Fibrillin
Mutations in the fibrillin 1 gene cause Marfan syndrome which includes tall stature, 
cardiovascular anomalies, joint laxity, lung abnormalities and diaphragmatic 
eventration amongst its features (Neptune, Frischmeyer et al. 2003; Revencu, 
Quenum et al. 2004; Robinson, Arteaga-Solis et al. 2006).
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1.3 Pulmonary Development and Pulmonary Complications
Congenital Diaphragmatic Hernia is inextricably linked to pulmonary hypoplasia, 
pulmonary hypertension and lung development.
1.3.1 Normal lung development
1.3.1.1 Stages of Lung Development
Normal lung development in the human begins during the fourth week of gestation 
when the lung bud forms as a ventral outgrowth of the foregut and continues until 
early childhood when it is considered to be complete (Boyden 1977). This can be 
divided into five stages (Zeltner and Burri 1987).
1. The embryonic stage, from fertilization until approximately 7 weeks.
2. The pseudoglandular stage, 5-17 weeks, by the end of this stage all major 
elements have formed except those involved with gas exchange.
3. The canalicular stage, (Zeltner, Caduff et al. 1987)16-25 weeks, the 
lumens of the bronchi and terminal bronchioles have become larger and the lungs 
vascularised. By week 24 respiratory airways have formed and respiration is 
possible, although the chances of survival are slim.
4. The saccular stage, more terminal sacs appear and the capillaries 
develop a close relationship with them. The sacs are lined with type 1 alveolar cells 
or type 2 pneumocytes which secrete surfactant counteracting the surface tension 
forces and facilitating expansions of the terminal sacs. The surfactant usually 
reaches adequate levels two weeks before birth.
5. The alveolar stage, late fetal period until a few years after birth, a newborn 
infant has only a small proportion of the alveoli of an adult. 95% of alveoli develop 
after birth.
Among different species the timing and duration of these stages may overlap.
1.3.1.2 Early Embryonic Development of the Lung and the Relationship of 
Animal Models to Human Lung Development
Although the development of the human lung has been studied, most of our 
understanding of lung embryology and growth has come from animal models due to 
their accessibility and availability. The creation of knock out, knock in and
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teratogenic models has permitted the study of the roles of genes, transcription 
factors and other factors such as the retinoids involved in the development and 
branching morphogenesis of normal lung. The expression patterns of these factors 
are well preserved between species including invertebrates, even though the timing 
of the mechanisms may differ slightly (Ghabrial, Luschnig et al. 2003). This allows 
for a cautious translation of these factors to study the development of the normal 
human lung, as required by the organism for a continuous and adequate oxygen 
supply after birth.
The lung is an appendage of the foregut; some of the key transcription factors 
essential for the formation and maintenance of the foregut are also important in lung 
development. These include Forkhead box gene A1 (FoxA1), Forkhead box gene 
A2 (FoxA2), GATA4 and GATA6 (Wan, Xu et al. 2004; Capo-Chichi, Rula et al. 
2005; Wan, Dingle et al. 2005). As a number of organs bud at specific times from 
the foregut there must be some signalling mechanism that allows each cell to know 
its relative position. This could include signals from the surrounding structures or a 
morphogenic gradient along the foregut tube such as bone morphogenic protein 2 
(Tiso, Filippi et al. 2002) and retinoic acid (Stafford and Prince 2002; Stafford, White 
et al. 2006). There is evidence that both signalling mechanisms and gradients may 
be involved in this process. Embryos treated with BMS493, an inverse pan-retinoic 
acid receptor agonist, had absent pancreas and liver markers. However, the 
structures derived from the anterior region of the foregut, the thyroid and lungs were 
unaffected (Stafford and Prince 2002) indicating a gradient (Kinane 2007). Bone 
morphogenic proteins via GATA4 and fibroblast growth factors from the primitive 
heart are critical for the localisation of foregut derived organs (Rossi, Dunn et al. 
2001). Using lung organ culture Serle and colleagues found that lung specification is 
induced by adjacent cardiac mesoderm but that it is replaceable by fibroblast growth 
factors 1 and 2 (Serls, Doherty et al. 2005). Morphogen gradients are critical for the 
induction of the lung. Retinoic acid, sonic hedgehog, fibroblast growth factors 1 and 
2 and bone morphogenic protein 4 are known to define cell position in the foregut. 
These signalling molecules are highly conserved and are used frequently during 
fetal development with different effects. The understanding of the signals required 
for lung bud initiation are incomplete and involve many factors but Sonic hedgehog 
is likely to be critical for the lung cascade and fibroblast growth factors are a 
probability (Kinane 2007).
37
1.3.2 Factors Involved in Lung Development 
1.3.2.1 Retinoic Acid Signalling Pathway
Mechanisms controlling retinoic acid signalling are critical for normal branching 
morphogenesis of the embryonic lung, and retinoic acid signaling is detectable in 
the lung from the very beginning of organogenesis (Wilson, Roth et al. 1953; Malpel, 
Mendelsohn et al. 2000).
The lung requires retinoic acid for organogenesis (Chytil 1996; Morriss-Kay and 
Sokolova 1996; Massaro and Massaro 1997). Retinoic acid from the splanchnic 
mesoderm surrounding the endoderm is required for stimulating the posterior 
foregut endoderm to a lung fate in the mouse (Malpel, Mendelsohn et al. 2000). In 
retinoic acid deficient mouse embryos the primary lung bud is specified but does not 
express the retinoic acid inducible homeobox A5 (hoxa5) gene. It is also unable to 
achieve outgrowth or branching morphogenesis. This results in a lack of fibroblast 
growth factor 10 (fgf10) expression and signalling in the lung epithelium. However 
lung budding and branching can be restored by treatment with fgf10 in these retinoic 
acid deficient embryos (Wang, Dolle et al. 2006).
At the onset of lung development abundant retinoic acid signalling is activated in 
primary lung buds. Further airway branching requires downregulation of retinoic 
pathways in a proximal distal gradient with less retinoic acid expression in the 
mesenchyme near the sites of terminal budding (Mollard, Ghyselinck et al. 2000). 
This decreased response can be ascribed to decreased levels of retinaldehyde 
dehydrogenase 2 limiting ligand availability, and an increase in chicken ovalbumin 
upstream promotor-transcription factor 11 (coup-tf11) f(Jonk, de Jonge et al. 1994) 
that antagonises retinoid signalling (Malpel, Mendelsohn et al. 2000). Manipulating 
retinoic acid levels to maintain the high levels of retinoic acid signalling present 
during the onset of lung development, leads to an immature lung phenotype with 
absent formation of typical distal buds (Cardoso, Williams et al. 1995). This alters 
the levels and distribution of fgf10 and bone morphogenic protein 4 (bmp4) genes 
that are essential for distal lung formation (Malpel, Mendelsohn et al. 2000). High 
levels of retinoic acid stabilise proximal tubule formation (Chazaud, Dolle et al. 
2003). If retinoic acid signalling is blocked by BMS483 a pan retinoic acid receptor 
antagonist, fgfW, bmp4, Sonic hedgehog (Shh), thyroid transcription factor 1 (ttf1) 
and GATAd expression are all increased. This results in increased branching 
(Chazaud, Dolle et al. 2003; Wongtrakool, Malpel et al. 2003).
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Loss of retinoic acid signalling in the foregut results in upregulation of transforming 
growth factors (tgf) (31 and /82 target genes. Exogenous administration of retinoic 
acid in vitro upregulates forkhead box gene A2 (foxa2) and tgffi both inhibitors of 
branching (Chazaud, Dolle et al. 2003; Wongtrakool, Malpel et al. 2003). Treatment 
of wild type embryos with exogenous tgf(31 reproduces the lung bud defect seen in 
the retinoic acid deficient embryos (Chen, Desai et al. 2007). These data support a 
novel mechanism of tgf(3, foxa2, retinoic acid and fgf10 interactions in the 
developing foregut. Endogenous retinoic acid controls tgf(3 activity in the prospective 
lung field, allowing the fgf10 expression necessary for the induction of lung bud 
formation and subsequent branching morphogenesis. (Chen, Desai et al. 2007).
Retinaldehyde dehydrogenase-2 deficient embryos can be rescued from early 
lethality by maternal dietary retinoic acid between 7.5 to 8.5 dpc but they fail to 
develop lungs and lack retinoic acid signalling in the foregut. (Chen, Desai et al.
2007) .
1.3.2.2 Fibroblast Growth Factor 9 (FGF9)
Fibroblast growth factor 9 (FGF9) has roles in both the growth and branching of the 
lung and the development of the vascular system. Vascular development matches 
branching morphogenesis from 10.5dpc in the mouse forming a dense capillary 
network surrounding the distal epithelium (Gebb and Shannon 2000; Schachtner, 
Wang et al. 2000; Parera, van Dooren et al. 2005). The mesothelial cells are the 
source of the vascular smooth muscle cells in the developing lung (Que, Wilm et al.
2008) . Fgf9 and shh regulate vascular endothelial growth factor A (vegfa) 
expression, essential for the formation of the pulmonary vasculature and for 
epithelial branching morphogenesis; Fgf9 null mice embryos have defective blood 
vessel development (White, Lavine et al. 2007). Fgf9 has a role in suppressing cell 
differentiation; embryonic lung explants treated with fgf9 inhibit shh induced smooth 
muscle differentiation (Weaver, Batts et al. 2003; Yi, Domyan et al. 2009). Fgf9 null 
mice have severe lung hypoplasia and reduced mesenchyme caused by a reduction 
in mesenchymal proliferation at 10.5 to 11.5dpc. They also have reduced branching 
of epithelial tubules This may be due to fgf9 interacting with fgf10 leading to reduced 
fgf10 expression in the mesenchyme of the actively branching areas of the lung, the 
terminal buds (Colvin, White et al. 2001).
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1.3.2.3 Fibroblast Growth Factor 10 (FGF10)
As well as early lung bud specification as previously discussed fgf10 has a 
significant role in the branching and development of the lung. FGF10 is required by 
the lung for the formation of lung buds and therefore for branching morphogenesis, 
fgf10 null mice have no lung development but do have a diaphragm. Retinoic acid 
acts upstream of fgf10 signalling in the developing lung and stomach (Wang, Dolle 
et al. 2006). Fgf10 is expressed in the distal mesenchyme at the budding tip and 
acts as a chemoattractant for the development of a new bud (Park, Miranda et al. 
1998).
From lung culture studies it has been shown that fgf10, fgf1 and fgf7 have 
overlapping capacities to stimulate lung growth and branching morphogenesis 
(Bellusci, Grindley et al. 1997; Cardoso, Itoh et al. 1997).
1.3.2.4 Sonic Hedgehog (SHH)
Sonic hedgehog (SHH) is essential for functional lung formation and is expressed in 
all pulmonary epithelial cells, the highest expression at the tips of the endbuds 
(Bellusci, Furuta et al. 1997; van Tuyl and Post 2000; Shannon and Hyatt 2004). 
With its receptor patched (ptc) shh acts as a morphogen and is one of the factors 
involved in region specific morphogenesis and initiation of organ specific 
developmental programs (Shannon and Hyatt 2004; Lu, Izvolsky et al. 2005). 
Overexpression of Shh shows increased mesenchymal and epithelial proliferation 
leading to an excess of mesenchyme (Chuang, Kawcak et al. 2003), (Bellusci, 
Furuta et al. 1997).
Shh is a regulatory factor in branching morphogenesis and affects the differentiation 
of the peripheral lung mesenchyme towards the smooth muscle lineage (Miller, Wert 
et al. 2004). Shh null mice have abnormal lung phenotype, lack of asymmetry, 
hypoplastic lobes, undivided oesophagus and trachea, reduced mesenchymal 
proliferation and greatly reduced branching (Pepicelli, Lewis et al. 1998).
1.3.2.5 Bone Morphogenic Protein 4 (BMP4)
Bone morphogenic protein 4 (BMP4) is expressed in the distal epithelium where it 
promotes distal epithelial and mesenchymal development. It also has a role in 
specifying smooth muscle precursors and antagonising FGF10 mediated epithelial 
budding (Bitgood and McMahon 1995; Bellusci, Henderson et al. 1996; Weaver, 
Dunn et al. 2000; Mailleux, Kelly et al. 2005). Interactions between mainly FGF9,
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FGF10, SHH and BMP4 control the budding necessary for branching 
morphogenesis (Weaver, Yingiing et ai. 1999; Malpel, Mendelsohn et al. 2000).
1.3.2.6 Thyroid Transcription Factor! (TTF1) or (more recently known as 
NKX-2-1)
Thyroid transcription factor-1 (TTF1) is a protein which is encoded by the NK2 
homeobox 1 (NKX2-1) gene and expressed in the thyroid and forebrain during 
development (Lazzaro, Price et al. 1991; Lee, Cho et al. 2001; DeFelice, 
Silberschmidt et al. 2003). Ttf1 is detected early in the endodermal cells of the lung 
anlage and may have a role in ceil determination (Lazzaro, Price et ai. 1991). 
During development ttf1 expression is localised to the epithelial cells of the 
branching lung buds and the expression decreases in the proximal airways as the 
lung grows. It is almost absent in the post natal lung apart from type 11 cells 
(Stahlman, Gray et al. 1996; Morotti, Gutierrez et al. 2000). Ttf1 knockout mice have 
only a rudimentary bronchial tree without branching and no distal parenchyma but 
overexpression of ttf1 has no effect on branching morphogenesis. It does however 
reduce alveolarisation (Wert, Dey et al. 2002).
1.3.2.7 Transforming Growth Factor p (TGFfi)
The transforming growth factor p (TgffS) family both influence lung development and 
are involved in lung disease. There are three isoforms of Tgffi all expressed at high 
levels during lung development and are particularly important for branching 
morphogenesis, epithelial cell differentiation and surfactant synthesis (Bartram and 
Speer 2004). TgffB is also involved in tissue repair following lung injury, chronic lung 
disease of prematurity and vascular remodelling in pulmonary hypertension 
(Bartram and Speer 2004).
Tgff3 has an inhibitory effect on branching morphogenesis by influencing the 
proteoglycans and metalloproteinases implicated in branching (Hildebrand, Romans 
et al. 1994; Sakurai and Nigam 1997; J, Tefft et al. 1998). It also hampers the 
activity of ttf1 and foxa2 by trapping them in the cytoplasm of cells (Kumar, 
Gonzales et al. 2000) and interferes with other peptide growth factors implicated in 
branching morphogenesis (Zhao, Sime et al. 1998).
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1.3.2.8 Friend of GATA2, (FOG2) and GATA 4
Friend of GATA2 (F0G2) is the first gene implicated in the pathogenesis of 
nonsyndromic human diaphragmatic defects and is also necessary for pulmonary 
development indicating this gene could be responsible for the primary pulmonary 
developmental abnormalities in neonates with diaphragmatic defects (Ackerman, 
Herron et al. 2005).
In a screen of fetal mice carrying chemically induced genetic mutations in the fog2 
gene, abnormal diaphragm development was present and small lungs were evident. 
The lungs had primary morphological defects such as the specific loss of the 
accessory lobe on the right lung and small underdeveloped right anterior middle 
lobe (Ackerman, Herron et al. 2005). In normal mouse development at 11.5dpc 
there was an increase in expression of fog2. The zinc finger domain containing 
transcription factor GATA4 is expressed in early mesenchymal and mesothelial cells 
of the lungs, great vessels, heart and diaphragm and like its co-regulator FOG2 is 
expressed in the early embryonic development of these organs. The expression and 
activity of GATA4 is influenced by retinoids (Arceci, King et al. 1993; Kostetskii, 
Jiang et al. 1999; Clabby, Robison et al. 2003; Ghatpande, Brand et al. 2006). 
Expression pattern indicates GATA4 plays a functional role in organogenesis in the 
organs in which it is expressed (Crispin©, Lodish et al. 2001; Jay, Bielinska et al. 
2007). Pulmonary expression of GATA4 is restricted to mesodermal derivatives and 
the airway defects are probably the result of impaired signaling from the 
mesenchyme or mesothelium to endoderm (Jay, Bielinska et al. 2007). While 
GATA4 heterozygous mice develop hernias in the ventral midline, gross inspection 
of the lungs mostly resembled those of the wild type mice. Some of the 
heterozygote mice had some dilated distal airways and thickened mesenchyme 
particularly around the accessory and middle lobes of the right lung (Jay, Bielinska 
et al. 2007). This is also the area from where the majority of lung peristaltic waves 
originate (Jesudason, Smith et al. 2005). In these GATA4 heterozygous mice the 
production of surfactant protein and clara cell secretory protein was found to be 
delayed (Jay, Bielinska et al. 2007).
1.3.2.9 Slit 2, Slit 3 and Roundabout (ROBO) 1 and 2
Two Slit genes, Slit-2 and Slit-3 and two Roundabout genes ROBG1 and ROBG2 
are expressed in the central nervous system where they act as a guidance 
mechanism (Whitford, Marillat et al. 2002). Slit-Robo interactions repulse cells away 
from or attract cells to specific targets (Kramer, Kidd et al. 2001). Slit and Robo
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expression has been documented in non neural tissue, the developing kidneys and 
limbs (Piper, Georgas et a!. 2000; Vargesson, Luria et al. 2001). Slit and Robo are 
expressed in the developing mouse lung and mostly restricted to mesodermal 
derivatives where they have a role in the positioning and alignment of the early 
vascular network and airways (Greenberg, Thompson et al. 2004). Production of 
smooth muscle alpha actin colocalises with Robo2 expressing mesenchyme and the 
interactions may determine the position of the airway smooth cell precursors 
(Greenberg, Thompson et al. 2004).
1.3.2.10 Forkhead Box Gene A2 (FOXA2) formally Hepatocyte Nuclear 
Factor-3p
Members of the forkhead box family of transcription factors share homology in the 
winged helix binding domain and play an important role in the expression of genes 
(Tuteja and Kaestner 2007; Tuteja and Kaestner 2007). Early in development of the 
lung the expression of foxa2 is mainly in the trachea and later restricted to distal 
airways, the expression pattern being very similar to that of ttf1 (Zhou, Lim et al. 
1996). Foxa2 modulates the expression of ttf1 and foxa2 and also inhibits branching 
in the developing lung (Zhou, Dey et al. 1997; Chazaud, Dolle et al. 2003).
1.3.2.11 Transforming Growth Factor a (TGFa) and Epidermal Growth Factor 
(EGF)
These are both members of the epidermal family of growth factors and are present 
in bronchial and bronchiolar epithelium (Ruocco, Lallemand et al. 1996). They have 
a role in stimulating branching in a dose dependant manner (Warburton, Seth et al. 
1992).
1.3.2.12 Wingless-Related MMTV Integration Site Family Members (WNT)
Wingless-related MMTV integration site family members (WNT) growth factor family 
are secreted glucoproteins which bind to a cell surface receptor and initiate 
signaling. Wnt signaling controls many embryonic processes including cell growth, 
migration, differentiation and fate (Cadigan and Nusse 1997; Wodarz and Nusse 
1998; Roth-Kleiner and Post 2005).
Several members of the wnt family are expressed in the developing lung and three 
have been linked to airway branching (Lako, Strachan et al. 1998; Pepicelli, Lewis 
et al. 1998; Weidenfeld, Shu et al. 2002) as detailed below.
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Wnt2 is expressed in the airway bud tip mesenchyme and may have a relationship 
with Shh but wnt2 null mice display no lung phenotype (Bellusci, Henderson et al. 
1996).
Wnt5a expression has a gradient along the airways, maximum expression is in the 
epithelium of the airway endbud (Li, Xiao et al. 2002). Inactivation of wnt5a causes 
shortened limbs and trachea, overexpansion of distal airways and an immature 
lung. Absence of wnt5a leads to increased expression of fgf10, bmp4, shh and its 
receptor patched (ptc) indicating that wnt5a, fgf10, bmp4 and shh are functionally 
interactive (Yamaguchi, Bradley et al. 1999; Li, Xiao et al. 2002).
Wnt7b is exclusively expressed in the epithelium, maximum expression at the tip of 
the branching endbuds (Pepicelli, Lewis et al. 1998) and reduced function of wnt7b 
leads to reduced mesenchyme surrounding the distal airways and lung hypoplasia 
incompatible with life (Shu, Jiang et al. 2002). Wnt7b expression is regulated by ttf1, 
GATA6 and foxa2 (Weidenfeld, Shu et al. 2002). Deficiency in wnt7b expression 
also leads to severe defects in the smooth muscle component of the major 
pulmonary vessels. This leads these vessels to rupture after birth indicating its 
requirement for proper mesenchymal and vascular development (Shu, Jiang et al. 
2002).
1.3.2.13 Insulin Like Growth Factors (IGF), their Receptors (IGFR) and their 
Binding Proteins (IGFBP)
Insulin like growth factors are peptide growth factors with a high sequence similarity 
to insulin and are expressed in the lungs of humans, rodents and other species 
(Maitre, Clement et al. 1995; Schuller, van Neck et al. 1995). This system consists 
of two cell surface receptors, Insulin-like growth factor 1 receptor (IGF1R) insulin­
like growth factor 2 receptor {IGF2R), two ligands insulin-like growth factor 1 (IGF1) 
and insulin-like growth factor 2 (IGF2) and a family of insulin-like growth factor 
binding proteins (IGFBP)1 to 6. IGFs and their binding proteins play a role in 
abnormal and normal fetal growth (Chard 1994). They are involved in growth 
hormone stimulation and bone development (Baker, Liu et al. 1993).
The insulin like growth factor system plays a key role in lung development by the 
interaction of IGFBP3 and IGFBP5 with the retinoid signaling pathway (Liu, Lee et 
al. 2000). Both IGFBP3 and IGFBP5 have an effect on cell growth by modulating 
gene expression (Ricort 2004). They are expressed in the distal airway epithelium
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and mesenchyme of the developing lung, their expression increasing as gestation 
advances (Ruttenstock, Doi et al. 2010).
During fetal lung development insulin modulates the cellular uptake of glucose a 
substrate for surfactant phospholipids and may be a bioregulator of surfactant 
synthesis (Felts 1964).
Insulin-like growth factor binding protein 3 (IGFBP3) regulates apoptosis (Liu, Lee et 
al. 2000).
Deletions of the chromosomal site of the IGF1R gene in humans has been reported 
in several cases of congenital diaphragmatic hernia (Rubin and Baserga 1995)
1.3.2.14 Basic Helix Loop Helix (bHLH)
Capsulin (Pod-1) is a basic helix loop helix factor that is expressed in the developing 
lung mesenchyme. Pod-1 knockout mice have no alveoli, hypoplastic lungs and 
defective branching morphogenesis (Quaggin, Schwartz et al. 1999; Maeda, Dave 
et al. 2007).
1.3.3 Extracellular Matrix (ECM)
As discussed previously the extracellular matrix includes the interstitial matrix and 
the basement membrane and is the scaffold providing structural support for the 
cells, segregating tissues from one another, regulating intercellular communication 
and dynamic behaviour. Several extra matrix molecules are involved in the process 
of branching morphogenesis of the lung.
1.3.3.1 Proteoglycans
Proteoglycans are proteins that have glycosaminoglycans attached to their serine 
residues. The proteoglycan heparan sulphate is a major component of the extra 
cellular matrix and is on the surface of most cells. It plays a pivotal role in cell to cell 
communications (Ori, Wilkinson et al. 2008). Heparan sulphate proteoglycans form 
tertiary structures with growth factors and their receptors, modulating the signaling 
of the growth factors and their receptors (Tumova, Woods et al. 2000; Kresse and 
Schonherr 2001).
Most extracellular proteins involved in embryonic development interact with heparan 
sulphate/heparin (Ori, Wilkinson et al. 2008), included are the proteins important for
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lung morphogenesis (Warburton, Schwarz et al. 2000; Thompson, Jesudason et al. 
2010).
Chondroitin sulphate proteoglycans provide tissue rigidity and stimulate fibroblast 
proliferation (Zhang, Cao et al. 1998). In vitro reduced sulfation of 
glycosaminoglycan reduces lung branching (Shannon, McCormick-Shannon et al. 
2003). This is caused by the reduction of the binding of fgf10 causing a loss of fgf10 
signaling, therefore reducing fgf10 dependant branching morphogenesis (Powers, 
Mcleskey et al. 2000). Fgf9 and tgf(3 and other growth factors are also similarly 
affected by the reduced sulfation of glycosaminoglycan (Zhao, Lee et al. 1998).
1.3.3.2 Elastin
Elastin is a major component of the mammalian lung and localises in the 
mesenchyme next to the airway indicating a role in airway formation (Wendel, 
Taylor et al. 2000). Elastic fibres are required for the proper expansion and recoil of 
the lungs (Schellenberg, Liggins et al. 1987). Elastin is first expressed in the 
extracellular matrix and associated with sites of airway branching (Wendel, Taylor et 
al. 2000; Mychaliska, Officer et al. 2004)
Early branching is not affected in elastin deficient mice but distal branching is 
impaired later in fetal development. At 18.5dpc elastin deficient mice have dilated 
distal air sacs. This mechanism is not at present fully understood (Wendel, Taylor et 
al. 2000). Elastin therefore has roles in the structure and function, of the lung, 
essential for pulmonary development and terminal airway branching. Lungs of mice 
with deleted retinoic acid receptor have reduced elastin content (McGowan, 
Jackson et al. 2000).
1.3.3.3 Tenascin
Tenascin is a multifunctional protein located at the epithelial-mesenchymal interface 
of the developing lung (Zhao and Young 1995; Kaarteenaho-Wiik, Kinnula et al. 
2001) and accumulates at sites where new airway branches form indicating a role in 
airway division (Koch, Wehrle-Haller et al. 1991). Both tenascin null mice and fetal 
lungs cultured with tenascin antiserum have a simplified branching pattern (Koch, 
Wehrle-Haller et al. 1991; Young, Chang et al. 1994).
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1.3.3.4 Fibronectin
Fibronectin is also a major component of the pulmonary ECM. Inhibition of 
fibronectin reduces branching morphogenesis in the lungs and addition of 
fibronectin to lung explants increases branching (Roman, Crouch et al. 1991; Sakai, 
Larsen et al. 2003). Fibronectin is required for cleft formation in branching 
morphogenesis of the lung and induces cell to cell adhesions and cell to matrix 
adhesions (Sakai, Larsen et al. 2003).
1.3.3.5 Laminin
Laminins and collagen 4 together with nidogen, entactin and heparan sulphate 
proteoglycans build the scaffold of the basement membrane (Sannes and Wang 
1997). The basement membrane acts as a barrier to some cells and molecules and 
serves as attachment points and binding sites for others.(Sannes and Wang 1997; 
Miosge 2001). The nidogen proteins may serve as a link between collagen 4 and 
laminin 1 stabilising the basement membrane during embryogenesis (Miosge, 
Holzhausen et al. 2001).
1.3.3.6 Collagen
As previously discussed collagen is the major component of the extra cellular matrix 
scaffold. Ehlers-Danlos syndrome, a connective tissue disorder with abnormal 
collagen synthesis, has been reported with pulmonary hypoplasia but this is an 
infrequent finding (Pradhan, Deb et al. 2009).
1.3.4 Pulmonary Complications of Congenital Diaphragmatic Hernia
1.3.4.1 Pulmonary Hypoplasia and Pulmonary Hypertension
Respiratory failure is the main cause of death in the neonatal infant with congenital 
diaphragmatic hernia. Lung hypoplasia is a leading contributor to the lethality of 
congenital diaphragmatic hernia (Clark, Hardin et al. 1998). Traditionally pulmonary 
hypoplasia was thought to develop after the failure of diaphragmatic closure. 
Proposed mechanisms for this include compression of the fetal lung by herniated 
abdominal viscera (Harrison, Jester et al. 1980). Pulmonary hypoplasia, vascular 
remodelling and pulmonary hypertension are characteristic of the surgically created 
fetal sheep model of congenital diaphragmatic hernia indicating compression of the 
lung does play a role in the pulmonary problems. The ipsilateral lung suffers more 
compression therefore becoming more hypoplastic (Guilbert, Gebb et al. 2000;
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Jesudason, Connell et al. 2000; Keijzer, Liu et al. 2000; Acosta, Thebaud et al. 
2001).
Growth competition between liver and lung (Kluth, Tenbrinck et al. 1993) and failure 
of fetal diaphragmatic activity to maintain lung expansion (Harding and Hooper 
1996) are also implicated in these pulmonary problems. However myogenic 
differentiation factorl (MyoD) knockout mice have a markedly thinned and none 
functioning diaphragm. This results in pulmonary hypoplasia due to the lack of fetal 
breathing movements (Inanlou, Dhillon et al. 2003; Inanlou and Kablar 2003). MyoD 
and myogenic factors (Myf5) play a crucial role in muscularisation More recently 
findings from experimental models have suggested lung hypoplasia may also 
precede diaphragmatic closure (Iritani 1984; Kluth, Tenbrinck et al. 1993; 
Jesudason, Connell et al. 2000; Keijzer, Liu et al. 2000).
Unlike most other causes of respiratory failure in the newborn a significant 
proportion of infants with congenital diaphragmatic hernia do not respond to modern 
therapeutic interventions such as exogenous surfactant, high frequency oscillatory 
ventilation and inhaled nitric oxide. With the failure of conventional ventilator support 
extra-corporeal membrane oxygenation may be applied in some centres but this is 
highly invasive, labour intensive and expensive. Extra-corporeal membrane 
oxygenation bypasses the lung allowing pulmonary vascular resistance to lower but 
does not overcome the basic problem of lung hypoplasia and studies do not suggest 
benefit in survival. The mortality rate amongst children with congenital 
diaphragmatic hernia is 40% to 50%, mainly caused by the pulmonary hypoplasia 
and pulmonary hypertension. Morbidity remains significant in many cases, with 
chronic oxygen dependence, gastroesophageal reflux, poor growth, developmental 
delay, prolonged and frequent hospitalisation are all features of infants surviving 
with congenital diaphragmatic hernia (Smith, Jesudason et al. 2002).
The hypoplastic lungs of newborns with congenital diaphragmatic hernia show 
variable defects in airway branching, epithelial differentiation and alveogenesis 
(Kitagawa, Hislop et al. 1971). Fibroblast growth factors, transcription factors and 
heparin sulphate proteoglycans are morphogens involved in these specific stages of 
lung development (Warburton and Lee 1999).
It is well established that increased distension of the fetal lung accelerates lung 
growth and that reduced distension of the fetal lung decreases lung growth (Alcorn, 
Adamson et al. 1977).
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This consequence of impaired lung development in these infants has focused 
research on the developmental biology of the lungs and diaphragm to identify early 
therapeutic interventions. Pulmonary hypoplasia is now considered to be a primary 
defect and not secondary to the congenital diaphragmatic hernia (Keijzer, Liu et al.
2000) , therefore it is important that the interplay of factors involved in lung 
development are characterised. A fundamental intervention to correct the pulmonary 
hypoplasia and pulmonary hypertension may be necessary to have a significant 
input on the outlook for these infants (Smith, Jesudason et al. 2002).
1.3.5 Management of Congenital Diaphragmatic Hernia and Pulmonary 
Complications
1.3.5.1 Prognosis of Congenital Diaphragmatic Hernia
The prognosis of neonates born with congenital diaphragmatic hernia remains 
unsatisfactory despite advances in surgical and medical treatment. The degree of 
pulmonary hypoplasia and persistent pulmonary hypertension are the main factors 
that influence prognosis in isolated congenital diaphragmatic hernia (Boloker, 
Bateman et al. 2002) and are a significant factor in complex congenital 
diaphragmatic hernia that is with associated anomalies. The outcome for infants 
with accompanying cardiovascular malformations, comprising between 10-35% of 
cases, is very poor (Fauza and Wilson 1994; Graziano 2005).
For those infants with genetic associations include trisomies 13 and 18, syndromes 
such as Fryns, Coffin-Siris and Denys-Drash, survival is very poor with mortality as 
high as 93%, many succumbing during the antenatal period (Witters, Legius et al.
2001) .
1.3.5.2 Antenatal Diagnosis of Congenital Diaphragmatic Hernia
Diagnosis of congenital diaphragmatic is increasingly reported on antenatal 
ultrasound scans, confirmed by the presence of loops of bowel or stomach within 
the thoracic cavity. This diagnosis should lead to a careful search for associated 
anomalies such as cardiac and neural tube defects (Smith, Jesudason et al. 2002). 
However it has been shown that antenatal ultrasound diagnoses only approximately 
50% of cases (Adzick, Vacant! et al. 1989; Dillon, Renwick et al. 2000; Detti, Mari et 
al. 2001; Game, Haeusler et al. 2002; Thilaganathan 2002). Early diagnosis 
provides an opportunity for parental counselling by the clinical team to discuss
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prognosis and if required formulate a plan for delivery, preferably elective at an 
obstetric centre with available surgical expertise and medical support.
For isolated congenital diaphragmatic hernia defining accurate antenatal prognostic 
features has proved challenging. The major factor determining outcome is the 
degree of pulmonary hypoplasia, therefore estimation of lung growth would seem 
the logical prognostic indicator. Prognostic features including early diagnosis, 
polyhydramnios and the presence of an intrathoracic stomach bubble have been 
equated with poor prognosis but have not been found to be consistently reliable 
(Adzick, Harrison et al. 1985; Nakayama, Harrison et al. 1985; Adzick, Vacanti et al. 
1989; Burge, Atwell et al. 1989). Lung head ratio has been used as a prognostic 
indicator, using a ratio of right lung diameter to head circumference and can predict 
outcomes at the extreme end of the scale, a value of <0.6 correlating with 100% 
mortality (Lipshutz, Albanese et al. 1997; Sbragia, Paek et al. 2000). The lung head 
ratio is a less reliable prognostic indicator in the mid ranges. Fetal magnetic 
resonance imaging has been used as a three dimensional estimation of lung growth 
and initial reports are encouraging (Paek, Coakley et al. 2001).
1.3.5.3 Postnatal Diagnosis of Congenital Diaphragmatic Hernia
Postnatal diagnosis is usually made during the first few minutes of life, signs of 
congenital hernia include respiratory distress, a scaphoid abdomen and a 
mediastinal shift away from the side of the lesion.
1.3.5.4 Surgical Repair of Congenital Diaphragmatic Hernia
Surgical repair of neonatal congenital diaphragmatic hernia has remained with little 
variation in operative techniques. The timing of surgery has now changed favouring 
delayed surgery.
Failure of postnatal therapies to significantly improve the prognosis for children with 
congenital diaphragmatic hernia prompted paediatric surgeons to consider fetal 
surgery to repair the hernia. To address these hypothesis surgeons created a lamb 
model of congenital diaphragmatic hernia simulating antenatal closure of the defect 
improving survival at birth (Harrison, Bressack et al. 1980; Harrison, Jester et al. 
1980). This led to the experimental fetal surgery for human foetuses diagnosed with 
a severe congenital diaphragmatic hernia but without survival benefit over postnatal 
surgery suggesting at that time the antenatal risks of surgery were not justified 
(Harrison, Adzick et al. 1993; Harrison, Adzick et al. 1997). However more recently 
antenatal surgery has been performed more successfully on cases with a poor 
prognosis as detailed in the following section.
50
1.3.5.5 Antenatal Management of Congenital Diaphragmatic Hernia
Antenatal steroid therapy has been shown to improve morphological maturity and 
reduce excessive muscularisation of the pulmonary vasculature in animal models of 
congenital diaphragmatic hernia. A report has shown that antenatal steroid therapy 
has improved the outcome in the case of three fetuses with a poor prognosis (Van 
Tuyl, Hosgor et al. 2001; Ford, Kirby et al. 2002).
Prenatal intervention is now offered to cases where the predicted prognosis is poor 
consisting of percutaneous fetoscopic endoluminal tracheal occlusion (FETO) 
(Deprest and De Coppi 2012). This is believed to work by preventing egress of lung 
fluid therefore increasing airway pressure and inducing cellular proliferation. FETO 
also increases alveolar airspace and helps maturation of pulmonary vasculature 
(Khan, Cloutier et al. 2007). This procedure can either be reversed by removal of 
the FETO either later in utero or immediately after birth but removal in utero is 
preferred (Deprest and De Coppi 2012). Deprest and colleagues reported outcomes 
showing considerable increase in survival in severe cases by using FETO, from 
24% to 49% in cases of left sided congenital diaphragmatic hernia and from 0% to 
35% in cases of right sided congenital diaphragmatic hernia (Deprest and De Coppi 
2012).
1.3.5.6 Respiratory Management of Congenital Diaphragmatic Hernia
Early postnatal management is aimed at providing adequate oxygenation, avoiding 
high ventilator pressures to further damage the lungs aggravating the pulmonary 
hypertension accompanying the pulmonary hypoplasia.
Inhaled nitric oxide given to neonates to treat pulmonary hypertension has shown a 
variable response. A Cochrane review has shown an improvement in neonates with 
pulmonary hypertension from inhaled nitric oxide only if they do not have congenital 
diaphragmatic hernia (Oliveira, Troster et al. 2000; Finer and Barrington 2001; Finer 
and Barrington 2001).
High frequency oscillatory ventilation (HFOV) has been widely adopted; this method 
increases the ventilator rate to improve gas exchange and decrease barotraumas. A 
multicentre trial in North America indicated no benefit to preterm neonates with 
respiratory failure but several anecdotal reports indicate improvement in cases of 
congenital diaphragmatic hernia (Miguet, Claris et al. 1994). An Italian study 
reported outcomes over a ten year period showed an increase in survival from 67% 
to 94% by employing HFOV in the preoperative management. Surgical repair was 
also performed under HFOV (Cacciari, Ruggeri et al. 2001).
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Extra corporal membrane oxygenation (ECMO) was introduced in the late 1970s; it 
enables a period of lung rest by placing the infant on cardiopulmonary support. This 
allows a reduction in pulmonary vascular resistance whilst providing oxygenated 
blood from an artificial circuit. Evidence supporting the use of ECMO is conflicting, 
early favourable reports were flawed by the use of historical data (Johnston, 
Bashner et al. 1988; Atkinson, Ford et al. 1991; Finer, Tierney et al. 1992). A 
multicentre trial in the UK showed no benefit for infants with congenital 
diaphragmatic hernia but showed benefit for infants with respiratory failure. A 
Cochrane review however showed a survival advantage for all infants but less for 
infants with congenital diaphragmatic hernia (Al-Shanafey, Giacomantonio et al. 
2002; Elbourne, Field et al. 2002). Despite the lack of clear evidence ECMO is likely 
to remain a treatment for congenital diaphragmatic hernia (Smith, Jesudason et al. 
2002).
Permissive hypercapnia was first suggested by Wung in 1985 (Wung, James et al. 
1985). This technique allows infants to breathe normally on the ventilator which 
removes the necessity of sedation and avoids baratrauma. The risk of ensuing 
acidosis is controlled medically and impressive results have been reported using 
this technique (Moffitt, Schulze et al. 1995; Wung, Sahni et al. 1995; Boloker, 
Bateman et al. 2002).
Exogenous surfactant therapy is very effective at improving ventilation in premature 
infants but the benefits in cases of congenital diaphragmatic hernia are less clear 
(Jobe 1993; Yost and Soil 2000). Both lungs from the congenital diaphragmatic 
hernia lamb model and the nitrofen rat model have been shown to have reduced 
surfactant proteins (Glick, Stannard et al. 1992; Suen, Catlin et al. 1993; Hedrick, 
Kaban et al. 1997; Mysore, Margraf et al. 1998). The nitrofen rat model of congenital 
diaphragmatic hernia showed an early increase in pulmonary compliance but this 
was short-lived with no overall benefit. A small randomised trial in human infants 
also failed to demonstrate any sustained benefit (Lotze, Knight et al. 1994).
Liquid ventilation using fluorocarbons has increased lung volume and ventilator 
mechanics in congenital diaphragmatic hernia neonates with a dismal prognosis. 
Liquid ventilation may stimulate lung growth and increase pulmonary compliance 
(Major, Cadenas et al. 1995; Pranikoff, Gauger et al. 1996; Fauza, Hirschl et al. 
2001).
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1.4 Normal and Abnormal Sex Differentiation in the Embryo
1.4.1 Background
Sex reversal and indeterminate sex states are defined as the observed morphology 
of the genitalia not corresponding with the chromosomal sex state. It is estimated 
that 1 in 4600 live births have ambiguous genitalia (Gillam, Hewitt et al. 2010) and 
1 in 1000 live births show some form of disorder of sex development (Cui, Ross et 
al, 2004). Severe disorders of sex development present a unique challenge, both 
diagnostically and in terms of acute and longer-term management. These are 
relatively rare conditions usually requiring a multidisciplinary approach from the 
outset and the involvement of a tertiary centre for assessment and management 
recommendations.
Disorders of sexual development can be considered to be divided into three main 
groups:-
• Virilised 46XX disorders
• Under-virilised 46XY disorders
• Chromosomic problems represented by mixed gonadal dysgenesis
1.4.2 Clinical Aspects of Disordered Sex Development
1.4.2.1 The Clinical Team
Infants presenting with ambiguous genitalia should be evaluated by a 
multidisciplinary team that is dedicated to the evaluation and management of 
children and adults with suspected and confirmed disorders of sex development. A 
thorough knowledge of the underlying pathophysiology and the strengths and 
weaknesses of the investigative tools that are available for reaching a diagnosis are 
crucial (Brain, Creighton et al. 2010). In particular gender assignment remains a 
difficult decision involving various indicators and long term support. (Gillam, Hewitt 
et al. 2010; Gillam, Hewitt et al. 2011).
1.4.2.2 Increasing Incidence of Male Sex Developmental Disorders
The prevalence of male reproductive disorders, such as testicular cancer and 
impaired semen quality, is increasing in many, albeit in not all, countries (Main, 
Skakkebaek et al. 2010). These disorders are aetiologically linked with congenital 
cryptorchidism and hypospadias by common factors leading to perinatal disruption
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of normal testis differentiation, referred to as the testicular dysgenesis syndrome 
(Main, Skakkebaek et al. 2010). This could possibly be due to lifestyle and 
environmental factors (Brain, Creighton et al. 2010).
1.4.2.3 Malignancy
Disorders of sex development have been recognised as one of the main risk factors 
for development of type II germ cell tumours. Any disorder of sex development 
associated with a Y chromosome has an increased risk of germ cell tumours, such 
as seminomas/dysgerminomas and non-seminomas (e.g., embryonal carcinoma, 
yolk sac tumour, choriocarcinoma and teratoma) (Warne and Hewitt 2009). This 
type of tumour is also the most frequent malignancy in adolescent and young 
Caucasian males without any evidence of dysgenic gonads. This suggests there 
may be common aetiological mechanisms, either genetic, environmental or a 
combination of the two (Looijenga, Hersmus et al. 2010).
1.4.2.4 Psychological Aspects
There are psychological aspects of disorders of sexual development to be 
considered which will have effects on the patient’s quality of life. Clinical decisions 
such as gender assignment are often made with long lasting effects on quality of 
life. Timing of surgery and communication should be based on empirical evidence 
but this evidence is largely not available. Protocols need to be developed to 
evaluate interventions to facilitate the decision making of professionals and 
individuals to enhance the psychological outcome of the cases (Gorduza, Vidal et 
al. 2010; Vidal, Gorduza et al. 2010).
1.4.3 Outline of Sex Differentiation
Mammalian sex determination involves complex interacting networks of gene 
expression, hormonal and cellular signals leading to the development of male or 
female phenotype. These processes can be divided into three main areas:-
1. The genetic sex of the embryo is decided at fertilisation, depending on 
whether an X or Y bearing sperm fertilises the oocyte. This inheritance of the 
X or Y chromosome from the father starts the profoundly different journeys 
of male or female life.
2. The next stage of sexual differentiation occurs when the fate of the 
bipotential gonad is determined by the expression of the Y linked genic 
switch in the XY embryo or no expression in the XX embryo, determining the
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gonadal phenotype. The male and female journeys unfold during embryonic 
life when this switch on the Y chromosome is activated to start the 
undifferentiated gonadal primordium on the pathway towards testes 
development,
3. The third stage is governed by hormonal secretions from the developing 
testes, setting in train a cascade of morphological changes, gene regulation 
and molecular interactions to direct the characteristics of male differentiation. 
If this mechanism fails to occur alternative cellular and molecular events take 
place to direct the gonad towards the characteristics of female 
differentiation.
Thus one common primordium, part of the urogenital ridge, has the potential to 
develop into either one of two functionally and morphologically different organs, the 
ovaries or testes giving phenotypic sex.
1.4.4 Mechanisms that Underpin Sex Differentiation
1.4.4.1 Early Research
In 1947 Alfred Jost reported that when male rabbit embryos were castrated in utero 
before gonadal sexual differentiation all embryos developed as phenotypic females. 
He suggested that the default sexual phenotype is female and there must be a 
factor expressed before male phenotype could develop, he called this testis 
determining factor (TDF) (Jost 1947). He also transplanted fetal testes into female 
embryos and he found they developed as phenotypic males, therefore 
demonstrating that females have all factors necessary for the differentiation of a 
phenotypical male. His hypothesis was confirmed in 1990 (Berta, Hawkins et al. 
1990; Koopman, Munsterberg et al. 1990; Sinclair, Berta et al. 1990). This factor 
TDF was then defined as Sex determining region on the Y chromosome (SRY). 
Since then an increasing list of genes and cell lineages expressed in the genital 
ridges has been elucidated and the genetic pathways and interactions necessary for 
genetic phenotype are being understood. Jost also performed innovative 
experiments to study the differentiation of the reproductive tract based on the fact 
that the female reproductive system develops in the absence of any gonad (Jost 
1970).
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1.4.4.2 Development of the Gonads
The gonads, kidneys and adrenals derive from the urogenital ridge. These first 
stage early mammalian genital ridges are a paired undifferentiated primordium 
which can be divided into three segments.
1) The pronephros, near the caudal end which includes the adrenal 
primordium.
2) The mesonephros, the central region from which the gonad arises.
3) The metanephros, the most posterior region from which the kidney arises.
The urogenital ridge derives from the intermediate mesoderm, which contains the 
cell precursors that help form the mesonephros, kidneys, adrenal and gonads. Both 
testes and ovaries arise from the genital ridges in the mammalian embryo. They are 
both highly specialised and different organs but from the same origin. The 
development of the gonads can be divided into two stages. The first stage is the 
genital ridge, a bipotential gonad which is identical in both male and female. The 
second phase is the development of the testes or ovary.
The main steps of phenotypic human sex differentiation are as follows:-
1) The paramesonephric duct (Mullerian duct) develops next to the 
mesonephric duct (Wolffian duct) at gestational age six to seven weeks.
2) For male phenotypic development the Leydig cells in the developing 
testes secrete testosterone which is converted to the more active 
dihydrotestosterone (Wilson, Griffin et al. 1993) which is required for the 
development of male external genitalia. The Wolffian duct increases in 
size and differentiates into epididymis, vas deferens and prostate. 
Recently a secondary pathway for dihydrotestosterone production has 
been discovered. A family was discovered to have a mutation of an 
enzyme involved in this alternative pathway of dihydrotestosterone 
production causing disorders of sex development (Fluck, Meyer-Boni et 
al. 2011). This was the first case of this alternative pathway known in the 
human population, this pathway had only previously been identified in a 
marsupial (Fluck, Meyer-Boni et al. 2011).
Sertoli cells in the testes secrete Anti-Mullerian Hormone resulting in the 
regression of the Mullerian duct.
3) For female phenotypic development there is no development of the 
testes and without the hormonal influence of testosterone the Wolffian
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duct eventually degenerates. The Mullerian duct proliferates and forms 
the fallopian tube, uterus and the upper third of the vagina.
This development is under the control of many factors.
1.4.5 Factors Involved in the Bipotential Stage of Sex Determination
There are a number of cell progenitor lineages within the bipotential genital ridges 
each having the potential to differentiate into testicular or ovarian cell types under 
the influence of transcription factors, hormones and enzymes. The supporting cell 
precursor lineage, so named for their role in sustaining germ cells, are believed to 
be present in the early gonad. These cells have the potential to differentiate into 
either Sertoli cells in the testis or granulosa cells in the ovary (Albrecht and Eicher 
2001).
Sertoli cells are the first cell type known to differentiate within the gonad from 
bipotentia! precursors of the supporting cell lineage. They express SRY and are the 
first indication of testis development of the bipotential gonad. Within this area there 
is a single cell population of Steroidogenic Factor 1 {SF-1) immunoreactive cells 
named ‘adrenogenital primordia’ (Hatano, Takakusu et al. 1996; Morohashi 1999). 
Steroidogenic precursor cells have the potential to differentiate into either Leydig 
cells in the testis or theca cells in the ovary. These are also present in the early 
gonad (Merchant-Larios, Moreno-Mendoza et al. 1993).
Germ cells have the potential to follow the spermatogenic pathway or the oogenic 
pathway depending in which developing gonad they find themselves. The primordial 
germ cells do not arise in the genital ridges but originate at the base of the allointois 
at the posterior end of the primitive streak but at this point are not restricted to a 
germ cell fate as they can form extraembryonic mesoderm. When first seen in the 
developing mouse embryo at 7dpc they are in the region of the developing hindgut 
and enter the embryo with the hindgut as it invaginates where they leave the 
hindgut and pass into the forming urogenital ridges at 9.5dpc in the mouse.
The most important factors involved in the molecular processes controlling this 
phase are described below.
1.4.5.1 Paired Homeobox 2 (PAX2)
The transcription factor paired homeobox 2 (PAX2) is widely expressed during the 
development of both ductal and mesenchymal components of the urogenital
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system. Pax2 homozygous mice lack genital tracts, kidneys and ureters. These 
defects could be attributed to both mesechymal and ductal components of the 
urogenital system. However, human genetic defects in PAX2 result in renal- 
coloboma syndrome (hypodysplastic kidneys and optic nerve abnormalities) but 
they do not have genitourinary abnormalities (Torres, Gomez-Pardo et al. 1995).
1.4.5.2 Empty Spiracle Homolog 2 (EMX2)
The homeobox gene Empty spiracle homolog 2 (emx2) is a mouse homologue of a 
Drosophila head gap gene empty spiracles (ems) and is essential for the 
development of dorsal telencephalon (Yoshida, Suda et al. 1997).
Emx2 is expressed in the epithelial components of the developing urogenital 
system. In emx2 mutant mice the kidneys, ureters, gonads and genital tracts were 
absent and there was accelerated degeneration of the Wolffian duct and 
mesonephric tubules without the formation of the Mullerian duct. These mutants 
completely lacked gonads and genital tracts (Miyamoto, Yoshida et al. 1997). No 
human sex development defects in human cases of EMX2 have been described. 
Somatic mutations have been described in endometrial carcinomas and are a rare 
cause of schizencephaly (Noonan, Mutch et al. 2001). The function of emx2 has 
been linked to the wingless related MMTV integration site family members {wnt) 
signalling pathway during embryonic patterning in mice (Okamoto, Hirata et al. 
2010).
1.4.5.3 Wilms Tumour 1 (WT1)
Wilms Tumour 1 (WT1), a zinc finger transcription factor, is the product of the Wilms 
tumour suppressor gene. Zinc finger transcription factors are small protein structural 
motifs that can include one or more zinc ions to help stabilise their folds. Mutation 
analysis in humans and genetic experiments in mice revealed that WT1 has a role 
in development as well as tumour suppression. WT1 has at least 4 splicing variants 
and post transcriptional modifications of the WT1 pre-mRNA leading to the 
production of at least 24 isoforms increasing the complexity of WT1 action. WT1 is 
expressed widely in the human undifferentiated gonad, mesonephros and kidney 
(Armstrong, Pritchard-Jones et al. 1993). In WT1 null mice the gonads undergo 
apoptosis and the adrenal glands are also affected as they share a common 
primordium (Hatano, Takakusu et al. 1996; Moore, Mclnnes et al. 1999). WT1 also 
plays a role in the growth of the ureteric bud during kidney development (Moore, 
Mclnnes et at. 1999). Experiments using transgenic mice suggest that WT1
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activates a number of genes, and steroidogenic factor 1 (SF1) is believed to be a 
WT1 target (Wilhelm and Englert 2002).
During gonad formation WT1 has several potential targets, it controls SRY and 
wingless related MMTV integration site family member 4 (WNT4) expression, but 
the control of WNT4, may be an indirect effect (Sim, Smith et al. 2002). WT1 also 
controls dosage sensitive sex reversal, Adrenal hypoplasia congenital critical region 
on the X chromosome gene 1 (DAX1), WT1 expression precedes that of DAX1 and 
can activate the DAX1 promoter, the WT1-DAX1 pathway is an early event in 
mammalian sex differentiation and anti Mullerian hormone also seems to be 
activated by WT1 variants (Kim, Prawitt et al. 1999).
1.4.5.4 Steroidogenic Factor 1 (SF1)
Steroidogenic factor 1 (SF1) is expressed in the bipotential urogenital ridge and 
pituitary gland indicating a role in the hypothalamic- pituitary-gonadal axis (Wilhelm, 
Palmer et al. 2007). Lack of a functional SF1 gene in mice causes failure of adrenal 
and gonadal development and also pituitary and hypothalamus gonadotrope 
abnormalities. XY mice lacking a functional SF1 gene also show male to female sex 
reversal (Luo, Ikeda et al. 1994; Shinoda, Lei et al. 1995; Sadovsky and Dorn 2000).
1.4.5.5 Lim Homeobox Protein 9 (LHX9)
Transcripts of the LIM homeobox gene (Ihx9) are present in the urogenital ridges of 
mice at 9.5dpc, they then localise in the interstitial cells as morphological 
differentiation occurs. In mice lacking Ihx9 function germ cells migrate normally but 
the somatic cells of the genital ridge fail to proliferate and there is no formation of a 
discrete gonad. In the absence of testosterone and anti Mullerian hormone 
genetically male mice are phenotypically female. The expression of SF1, a nuclear 
receptor essential for gonadogenesis is reduced to minimal levels in the Ihx9 
deficient genital ridge. This indicates that Ihx9 may lie upstream of SF1 in a 
developmental cascade. Lhx9 null mice gonadal phenotype is similar to that of SF1 
and WT1 null mice, Ihx9 mutants have not been found to exhibit any additional 
developmental defects (Birk, Casiano et al. 2000). Although LHX9 mutations may 
underlie certain forms of isolated gonadal agenesis in humans as to date such 
mutations have not been found (Biason-Lauber 2010).
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1.4.5.6 GATA Binding Protein 4 (GATA4)
GATA Binding Protein 4 is a member of the GATA family of transcription factors. It 
is present in the gonads and may be a regulator of gene expression. In mice it 
marked the developing somatic lineages, Sertoli (testes) and granulosa (ovary) but 
did not mark the primordial germ cells. GATA4 expression remained abundant in 
Sertoli cells throughout embryonic development but shortly after the histological 
differentiation of the ovary at 13.3dpc GATA4 was downregulated. This pattern of 
expression indicates that GATA4 may be involved in early gonadal development 
and possibly sexual dimorphism (Viger, Mertineit et al. 1998). In humans GATA4 
has only been related to a specific heart defect, an atrial septal defect (Liu, Wang et 
al. 2011).
1.4.5.7 Chromobox Homologue 2 (CBX2 also known as M33)
It has been suggested that Chromobox Homologue 2 (CBX2) compacts chromatin 
thereby preventing the binding of transcriptional activators. Homozygous XY cbx2 
(M33) knockout mice have male to female sex reversal and XX cbx2 (M33) mice 
have absent or small ovaries (Katoh-Fukui, Tsuchiya et al. 1998). As CBX2 (M33) 
has a role in early gonad development of both sexes it indicates a role before the 
time of sex determination (Katoh-Fukui, Tsuchiya et al. 1998). Cbx2 (M33) has 
recently been implicated in SF1 regulation in the spleen and adrenal gland (Katoh- 
Fukui, Owaki et al. 2005) therefore it may have a similar function in gonad 
development but as yet this has not been confirmed (Wilhelm, Palmer et al. 2007). 
Cbx2 null mice also have other development defects and exhibit male to female sex 
reversal, retarded growth, skeletal anomalies and a failure of some cell types to 
expand. When these mutants are treated with retinoic acid the skeletal anomalies 
are aggravated indicating the cbx2 protein may have a role in defining access to 
retinoic acid response elements affecting the regulating region of several Hox genes 
which are genes determining the structure and orientation of the developing embryo 
(McGinnis and Krumlauf 1992; Core, Bel et al. 1997).
1.4.6 Overview of Development of Sexual Phenotype
Male and female embryos possess initially a bipotential gonad that becomes 
committed to ovary or testis development as a result of interactions between the 
mesenchymal cells. These ceils are derived from the mesonephros and the 
epithelial cells of the genital ridge (Schmahl and Capel 2003; Brennan and Capel 
2004).
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Sertoli cells are considered to be generated from the epithelium of the genital ridge, 
whereas many of the other somatic cell types, including endothelial cells and 
peritubular myoid cells, are derived from the mesonephros by migration into the XY 
gonad (Merchant-Larios, Moreno-Mendoza et al. 1993). The extragonada! germ 
cells are encapsulated into the seminiferous tubules encircled by the peritubular 
myoid cells
Desert hedgehog (DHH) is produced by Sertoli cells and regulates the proliferation 
and differentiation of Leydig cells (Yao, Whoriskey et al. 2002; Park, Tong et al. 
2007; Zou, Li et al. 2012). One of the important steps in male sex organogenesis 
occurs when the differentiating Sertoli cells start to secrete anti-Mullerian hormone. 
This induces regression of the female Mullerian duct, while the differentiating Leydig 
cells initiate the production of testosterone. Testosterone promotes the development 
of the other sex duct, the male Wolffian duct, into the epididymis, vas deferens, and 
seminal vesicles. Insulin-like factor 3, a hormone produced by the Leydig cells, is 
also implicated in Wolffian duct development because its deficiency leads to bilateral 
cryptorchidism (Hutson and Donahoe 1986; Nef and Parada 1999).
In females, the absence of anti-Mullerian hormone and testosterone and the 
presence of wnt-4 and wnt-7a signaling leads to development of the Mullerian duct. 
This forms the oviduct, uterus, and upper part of the vagina, and the degeneration of 
the Wolffian duct (Parr and McMahon 1998; Vainio, Heikkila et al. 1999; Heikkila, 
Peltoketo et al. 2002; Heikkila, Prunskaite et al. 2005).
1.4.7 Factors Involved in the Development of Male Sexual Phenotype
I. 4.7.1 Sex Determining Region on the Y Chromosome (SRY)
The default pathway in the genital ridges is considered to be ovarian development. 
In males the Y chromosomal testis determining gene (SRY) pre-empts the ovarian 
pathway diverting the genital ridges towards testicular development (Koopman 
2010). The presence of a Y chromosome results in male development regardless of 
the number of X chromosomes (Ford, Jones et al. 1959; Jacobs and Strong 1959).
Early studies in mice showed that SRY is first expressed around 10.5dpc shortly 
after the emergence of the genital ridges. Peak levels of expression are reached at
II. 5dpc and SRY expression is no longer detected shortly after 12.5dpc in the 
mouse (Koopman, Munsterberg et al. 1990; Hacker, Capel et al. 1995; Jeske, 
Bowles et al. 1995). The function of SRY seems to cause the supporting cell
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precursors to differentiate into Sertoli cells (Burgoyne, Buehr et al. 1988; Sekido, 
Bar et al. 2004; Wilhelm, Martinson et al. 2005). This was proved in 1991 using XX 
female transgenic mice expressing SRY and they developed testes as a result 
(Koopman, Gubbay et al. 1991). SRY triggers differentiation of Sertoli cells from 
supporting cell precursors which would otherwise have given rise to follicle cells. 
Sertoli cell differentiation is the pivotal event essential for male sex determination 
and testicular morphogenesis. There is evidence that Sertoli cells are the organising 
centres of the developing testes communicating with cells around them and 
secreting factors that bind to receptors on the receiving cells (Brennan and Capel 
2004).
Many mutations have been identified in human SRY, typically affecting the structure 
of the SRY protein therefore affecting male sex development. Such mutations result 
in disorders of sex development including sex reversal (Harley, Jackson et al. 
1992). The regulatory sequences required for directing the expression of SRY are 
also vulnerable to mutation as SRY is only expressed for a few days during the 
differentiation in the genital ridges. The SRY sequences have become so degraded 
that the level of expression is very low leaving only a minimum amount of 
expression to initiate testes development, leaving male sex determination 
vulnerable to perturbation. As the SRY gene is vulnerable to mutation or reduced 
expression, it is not a very robust sex determining mechanism. As it resides on the 
Y chromosome, if SRY becomes mutated some repair mechanisms are unavailable. 
This is due to a lack of a meiotic pairing partner, such as duplex repair which 
requires exchange of a DNA strand from one duplex to another (Bullejos and 
Koopman 2001). However not all mammals rely on SRY as the sex determining 
switch; in some species of spiny rats the males have no Y chromosome, they have 
XO/XO chromosome composition. The males have extra copies of chromobox 
homologue 2 (cbx2) gene and it suggests that these spiny rats have acquired a new 
sex determining gene that has superseded SRY, and SRY was lost with the 
disappearance of the Y chromosome (Kuroiwa, Handa et al. 2011). A girl with a Y 
chromosome having completely normal genitalia is considered to have mutation of 
gene CBX2 on chromosome 17 which has shut off the SRY gene. It is too early to 
assess her fertility (Biason-Lauber, Konrad et al. 2009).
SRY triggers the expression of a related gene SRY (sex determining region Y)-box9 
(SOX9J by binding to an enhancer sequence upstream of SOX9, Once SRY has 
managed to initiate the Sox9 feedback loop its expression is no longer required 
(Sekido and Lovell-Badge 2008). Up regulation of Sox9 in pre-Sertoli cells is one of
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the earliest markers of Sertoli cell differentiation (Kent, Wheatley et al. 1996; Morais 
da Silva, Hacker et al. 1996). Sox9 expression is then able to stimulate and 
maintain its own transcription through auto regulation, the Sox9 protein also being a 
transcription factor. This creates a positive feedback loop for the continued 
production of Sox9 protein independent of continued SRY expression ensuring 
continued testis development. If SRY is absent or expression fails at the critical 
time Sox9 is silenced and development of the follicle and ovary ensues.
1.4.7.2 SRY (Sex Determining Region Y)-Box9 fSOX9J
SRY(sex determining region Y)-box9 (SOX9J is considered the best candidate for a 
direct SRY target gene (Sekido, Bar et al. 2004; Wilhelm, Martinson et al. 2005; 
Sekido and Lovell-Badge 2008). SOX9 expression is upregulated soon after the 
expression of SRY begins. Cell mapping experiments indicate that SRY positive 
cells exclusively become SOX9 positive Sertoli cells (Chaboissier, Kobayashi et al. 
2004). Heterozygous mutations in SOX9 are responsible for camptomelic dysplasia, 
a condition in which most XY patients have male to female sex reversal. They also 
possess skeletal malformations due to the reduction of SOX9 activity which is 
required for type2 collagen formation, a major structural component of cartilage 
(Bell, Leung et al. 1997; Ng, Wheatley et al. 1997).
Targeted sox9 ablation in mice also leads to ovary development in XY embryos 
(Barrionuevo, Bagheri-Fam et al. 2006).
Sox9 is abolished in steroidogenic factor 1 (SF1J null mutant mice gonads 
suggesting SF1 to be a good candidate for initiating or sensitizing sox9 (Lovell- 
Badge, Canning et al. 2002; Sekido, Bar et al. 2004). Sox9 is expressed at a low 
level in the genital ridges of both sexes at 10.5dpc in the mouse, expression of 
which is sensitised by SF1. In the human male SF7, probably in conjunction with 
other factors such as WT1, also activates SRY expression. Therefore SOX9 
expression is upregulated by the action of SRY together with SF/. After the transient 
high levels of SRY have ceased high levels of SOX9 are maintained by its direct 
autoregulation and by Fibroblast Growth Factor 9.
1.4.7.3 Fibroblast Growth Factor 9 (FGF9) and its Receptor Fibroblast Growth 
Factor Receptor 2 (FGFR2)
In vivo and in vitro studies have suggested that Fibroblast Growth Factor 9 (FGF9) 
has several direct and indirect roles in male sex determination and testicular 
development (Colvin, Green et al. 2001; Schmahl, Kim et al. 2004; Willerton, Smith
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et al. 2004; El Ramy, Verot et al. 2005; Yoshioka, Ishimaru et al. 2005; Chi, Itaranta 
et al. 2006; Kim, Kobayashi et al. 2006)
Fgf9 is also implicated in Sertoli cell specification maintaining high levels of sox9. It 
is broadly expressed in the mouse embryo with a sex specific pattern in the 
developing gonad, in the Wolffian duct, the mesonephric tubules and the Sertoli 
cells of the developing testis (Colvin, Feldman et al. 1999). It can be detected from 
11.5dpc in both sexes (Schmahl, Kim et al. 2004) but later restricted to the testes 
cords of the XY gonad. Fgf9 null mice show male to female sex reversal most likely 
due to a reduced proliferation rate and possibly impaired differentiation rate of pre 
Sertoli cells. As a consequence the threshold number of required cells for testes 
differentiation is not met (Schmahl and Capel 2003). Fgf9 signaling stimulates 
mesenchymal cell proliferation and the migration of mesonephric cells into the testis 
(Colvin, Green et al. 2001), which is one critical cellular consequence of SRY 
activation, contributing to the formation of the interstitial compartment of the testis 
(Karl and Capel 1998).
Following SRY mediated upregulation of sox9 in the mouse at 11.5dpc, fibroblast 
growth factor receptor 2 (fgfr2) accumulates in the nuclei of Sertoli cells of the XY 
gonads (Schmahl, Kim et al. 2004). Deletion of fgfr2 in embryonic gonads has the 
same phenotype as deletion of fgf9 leading to male to female sex reversal. This 
indicates a distinct role for fgfr2 in proliferation and Sertoli cell differentiation during 
testis development in mice. Kim and colleagues were the first to report this genetic 
evidence (Kim, Bingham et al. 2007).
1.4.7.4 Steroidogenic Factor 1 (SF1) and Nuclear Receptor Subfamily 5 Group 
A Member 1, (NR5A1)
Steroidogenic factor 1 (SF1) is a member of the nuclear receptor family of 
intracellular transcription factors and is encoded by the Nuclear Receptor subfamily 
5 group A member 1 (NR5A1) gene (Taketo, Parker et al. 1995). The central role of 
SF1 is regulating adrenal development, gonad determination and differentiation, and 
in the hypothalamic-pituitary control of metabolism and reproduction. In the mouse 
SF1 is expressed in the early adrenogonadal primordium from 9dpc and thereafter 
in the developing adrenal gland and gonad (Ikeda, Shen et al. 1994; Nef, Schaad et 
al. 2005; Val, Martinez-Barbera et al. 2007). In humans SF1 expression has been 
shown in the bipotentiai gonad and developing adrenal gland at 32-33 days post 
conception (Ramayya, Zhou et al. 1997; Hanley, Ball et al. 1999). From around 42
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days post conception onwards in humans after testes determination SF1 expression 
is maintained in the somatic cells of the early testes where it may play a crucial role 
with SRY\n supporting SOX9 expression (Sekido and Lovell-Badge 2008).
From around 7 weeks gestation in the human male fetus the Sertoli cells expression 
of SF1 activates expression of anti-Mullerian hormone leading to the regression of 
the Mullerian ducts. Leydig cells differentiate later than Sertoli cells and their 
differentiation may be controlled by Sertoli cell secreted factors (Habert, Lejeune et 
al. 2001). From 8 weeks gestation SF1 activates the expression of Steroidogenic 
enzyme systems in the Leydig cells resulting in androgenisation of the external 
genitalia.
In XY mice deletion of the gene Nr5a1 encoding SF1 results in female external 
genitalia, Mullerian structures, complete testicular dysgenesis and impaired adrenal 
development. This prompted a search for a human counterpart focusing on patients 
with primary adrenal failure, 46XY gonadal dysgenesis and Mullerian structures. 
The first patient with this phenotype was identified in 1999 by Achermann and 
colleagues (Achermann, Ito et al. 1999). The phenotypic human anomalies with 
SF1/NR5A1 gene mutation range from complete testicular dysgenesis with 
Mullerian structures, severe penoscrotal or anorchia to cases of mild clitoromegaly 
or genital ambiguity (Lin and Achermann 2008), Heterozygote mutations in NR5A1 
have recently been linked to ovarian insufficiency although it is not essential for 
ovarian determination (Biason-Lauber and Schoenle 2000; Lourenco, Brauner et al. 
2009).
1.4.7.5 Basic Helix Loop Helix (bHLH)
Pod-1 (Capsulin), a member of the basic helix loop helix transcription factors is first 
expressed in the bipotential gonad at 11.5dpc in the mouse embryo. In the pod-1 
knockout mouse abnormalities are seen in the bipotential gonad at 11.5dpc. During 
male sex development the expression pattern of pod-1 is closely related to the 
pattern of expression of SF1. Pod-1 may repress SF1 expression and its absence 
may cause premature differentiation disrupting testicular structure and development. 
Both XX and XY pod1 knockout mice have hypoplastic gonads with vascular 
abnormalities. XY pod-1 knockout mice also have male to female sex reversal (Cui, 
Ross et al. 2004).
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1.4.7.6 Dosage Sensitive Sex Reversal and Adrenal Hypoplasia Congenital 
Critical Region on the X Chromosome Gene 1 (DAX1)
Dosage Sensitive Sex Reversal and Adrenal Hypoplasia Congenital Critical Region 
on the X Chromosome Gene 1 (DAX1) is encoded by the gene NROB1 and is 
expressed in the developing adrenal gland, the hypothalamus, the pituitary and in 
the somatic cells before the expression of SRY. During gonadal differentiation dax1 
expression is regulated by WT1 (Kim, Prawitt et al. 1999). Anti Mullerian Hormone 
promoter can be repressed by DAX1 and can displace Wilms tumourl (WT1) from 
its complex with SF1. (Wagner, Wagner et al. 2003). Nuclear receptors DAX1 and 
SF1 mediate somatic cell differentiation during testis development, DAX1 being an 
antagonist of SF1 (Achermann, Meeks et al. 2001; Iyer and McCabe 2004; Park, 
Meeks et al. 2005).
Loss of function of WT1 in male development causes impaired testicular 
development from reduced testicular size to complete sex reversal and dax1 is 
inhibited by coup-tf11 (Yu, Achermann et al. 1998; Yu, Ito et al. 1998; Yu, Ito et al. 
1998; Achermann, Meeks et al. 2001; Meeks, Crawford et al. 2003; Meeks, Weiss 
et al. 2003; Bouma, Albrecht et al. 2005). In mice and humans, sensitivity to levels 
of DAX1 is important and may have a window of activity (Ludbrook and Harley 
2004). Loss of function of dax1 and SF1 in mice reduced desert hedgehog (dhh) 
expression, dhh is a paracrine signalling factor regulating fetal Leydig cell 
development (Yao, Whoriskey et al. 2002).
1.4.7.7 GATA Binding Protein 4 (GATA4) and Friend of GATA2 (FOG2)
In mice of both sexes GATA4 is present in the gonads and marks the developing 
somatic cell lineages, Sertoli cells in the XY gonads and granulosa cell in the XX 
gonad. Both GATA4 and fog2 are required for fetal testes development in mice 
(Bouma, Affourtit et al. 2007; Bouma, Washburn et al. 2007). Mice having a 
homozygous mutation disrupting GATA4/fog2 interactions have male to female sex 
reversal (Tevosian, Albrecht et al. 2002; Barber, Maloney et al. 2005) In the 
absence of fog2 in mice the function of SRY was impaired leading to sex reversal 
(Tevosian, Albrecht et al. 2002). In humans mutations of GATA4 have been linked 
to heart defects only (Biason-Lauber 2010).
1.4.7.8 Paired Homeobox 2 (PAX2)
Paired homeobox 2 (PAX2) as well as having a role in the bipotential development 
of the urogenital ridge also continues to have a role in the development of sex
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differentiation and kidney development, Pax2 homozygous mutant mice lack 
kidneys, ureters and genital tracts due to dysgenesis of both ductal and 
mesenchymal components of the urogenital system. The wolffian and Mullerian 
ducts, precursors of the male and female genital tracts develop only partially and 
degenerate during embryogenesis (Torres, Gomez-Pardo et al. 1995).
1.4,7.9 Double Sex and MAB3-Related Transcription Factor 1 (DMRT1)
Human DMRT encodes a protein that is expressed only in testes. The DMRT genes 
are carried on chromosome 9p and monosomy of this area has been linked to sex 
reversal. Deletion of the short arm of chromosome 9 (9p) is linked to cases of 
gonadal dysgenesis and XY sex reversal. This suggests this region contains genes 
requiring two copies for normal testis development (Raymond, Parker et al. 1999; 
Muroya, Okuyama et al. 2000).
Mouse dmrtl is expressed in the developing urogenital ridges of XX and XY 
embryos and in the Sertoli cells and germ cells of the developing testes (Raymond, 
Kettlewell et al. 1999). Thus dmrtl and SRY are the only regulatory genes 
expressed exclusively in the urogenital ridge prior to sexual differentiation 
(Raymond, Kettlewell et al. 1999).
1.4.7.10Retinoic Acid, Retinaldehyde Dehydrogenase and Aldehyde 
Dehydrogenase Family 1, Subfamily A1
Vitamin A given to pregnant rats caused genitourinary anomalies in the offspring 
(Wilson and Warkany 1947). Retinoic acid controls some aspects of the 
development of the urogenital tract as retinaldehyde dehydrogenase isoforms are 
expressed in the mesenchymal cells of the mesonephros, stromal cells of the 
developing kidney and the ureteric bud. Here they control epithelial mesenchymal 
interactions during kidney development and for the development of connections 
between the ureters and bladder (Batourina, Gim et al. 2001; Mic, Haselbeck et al. 
2002; Batourina, Tsai et al. 2005).
When added to rat fetal testis in culture, exogenous retinoic acid inhibits Sertoli cell 
differentiation, mesonephric cell migration, seminiferous cord formation and 
gonocyte survival thus inhibiting XY gonadal development (Cupp, Dufour et al. 
1999; Livera, Rouiller-Fabre et al. 2000; Li and Kim 2004). Aldehyde 
Dehydrogenase Family 1, Subfamily A1 is an enzyme involved in retinoid 
metabolism and is expressed at high levels in mouse Somatic cells shortly after 
SRY expression is first detected and is dependent on sox9 expression (Bowles,
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Feng et al. 2009). A low level of retinoic acid may be necessary for male gonad 
development (Bowles, Feng et al. 2009).
1.4.8 Molecular Development of Sexual Phenotype (Female)
1.4.8.1 Wingless-Related MMTV Integration Site Family Member 4 (WNT4)
The wingless-related MMTV integration site family members (WNT) family of genes 
are structurally related genes which encode secreted signalling proteins from the 
extra cellular matrix. These proteins have been implicated in several development 
processes including regulation of cell fate and patterning during embryogenesis and 
also in oncogenesis. WNT4 is the first signalling molecule shown to influence the 
female sex determining cascade. The human WNT4 shows a 98% homology to the 
amino acid identity of mouse and rat WNT4 (Jordan, Mohammed et al. 2001).
WNT4 is the first human gene to be identified that directed the developmental of the 
bipotential gonad towards ovarian development. Ovarian development was 
considered to be the default pathway, but has been shown not to be a passive 
default pathway. WNT4 null XX mice show partial female to male sex reversal and 
reduced expression of follistatin limited to early ovarian development. This indicates 
a role in the initiation but not the maintenance of follistatin expression (Kashimada, 
Pelosi et al. 2011). WNT4 acts through follistatin to inhibit male specific 
vascularisation and maintain germ cell survival in the developing ovary (Tomizuka, 
Horikoshi et al. 2008).
WNT4 is produced in ovarian somatic cells and it upregulates dosage sensitive sex 
reversal, adrenal hypoplasia congenital region on the X chromosome genel (dax1), 
a gene known to antagonise the nuclear-receptor SF1 and SRY therefore 
preventing testicular development (Jordan, Mohammed et al. 2001). Also in the 
early stages of ovarian development WNT4 suppresses the migration of 
mesonephric endothelial and steroidogenic cells preventing the formation of male 
specific coelomic blood vessels and the production of steroids (Jeays-Ward, Hoyle 
et al. 2003; Yao, Matzuk et al. 2004). WNT4 It is implicated in Mullerian duct 
formation being required for the initial Mullerian duct formation in both sexes 
(Vainio, Heikkila et al. 1999).
A lack of WNT4 in the XX female mouse embryo leads to the mascularisation of the 
embryo, having no Mullerian structures but having a wolffian duct. However no 
Sertoli cell markers are expressed and no testicular tissue is formed. The external
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genitalia is phenotypically female indicating that WNT4 is not a primary sex 
determining gene (Bernard and Harley 2007). This has been corroborated by a 
single point mutation of the WNT4 gene in a human patient with similar phenotypical 
anomalies to the mouse model (Biason-Lauber, Konrad et al. 2004). XY mice 
generated to overexpress WNT4 showed no male to female sex reversal, (Jeays- 
Ward, Hoyle et al. 2003; Jordan, Shen et al. 2003), however in humans duplications 
of chromosome 1p including the WNT4 gene do show gonadal anomalies 
(Cousineau, Higgins et al. 1981; Elejalde, Opitz et al. 1984).
In the presence of Wolffian ducts in WNT4 knockout female mouse embryos 
steroidogenic enzymes that are required for the production of testosterone are 
expressed. These enzymes are normally suppressed in the developing ovary and 
the ovaries of these mice have less oocytes suggesting a role for WNT4 in germ cell 
development. Germ cells have a role in the organisation of ovarian structure and 
maintenance (Merchant 1975; McLaren 1984). WNT4 appears to protect germ cells 
in mice (Vainio, Heikkila et al. 1999) and probably in humans (Philibert, Biason- 
Lauber et al. 2008).
1.4.8.2 Follistatin (Fs#
Follistatin, (Fst) a secreted glycoprotein required for early female sex determination 
and ovarian development acts downstream from WNT4. It binds to the tgffi- 
superfamily molecules such as activin and neutralises their activity (Phillips and de 
Kretser 1998). The expression of Fst is restricted to the developing ovary and is not 
present in the developing testis (Menke and Page 2002; Yao, Matzuk et al. 2004). 
Fst is however expressed in many other organs, neuronal tissue, kidney, liver, bone, 
heart, muscle and skin. Fst null mice die soon after birth due to a wide range of 
affected organs confirming a broad range of biological roles (Matzuk, Lu et al. 
1995).
Follistatin null mice also displayed partial sex reversal during embryogenesis 
suggesting an earlier role in ovarian development. A deficiency results in the 
development of coelomic blood vessels in an XX gonad, coelomic blood vessels 
being a normal feature of testis development. (Yao, Matzuk et al. 2004).
1.4.8.3 Roof Plate Specific Spondin 1 (RSP01)
The R-spondin (RSPO) protein family is a recently described group of secreted 
proteins (Kim, Zhao et al. 2006), their activities are similar to those of the wnt 
ligands (Kazanskaya, Glinka et al. 2004; Kim, Kakitani et al. 2005). The expression
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pattern of Rspo mRNAs was shown to partially overlap that of wnt genes (Kamata, 
Katsube et al. 2004; Nam, Turcotte et al. 2007).
Roof plate specific spondinl (rspol) was first identified in the dorsal neural tube of 
mice (Kamata, Katsube et al. 2004). Rspol is expressed in the developing gonads 
of 11,5dpc mice, in the XX gonads it is expressed in the somatic cells but in the XY 
gonads expression is mostly restricted to the coelomic epithelium and weak 
expression showing in some interstitial cells from 12.5dpc (Parma, Radi et al. 2006; 
Chassot, Ranc et al. 2008).
Loss of function studies demonstrated that ablation of Rspol triggers sex reversal of 
XX mice with the formation of ovatestis and hermaphroditism of male and female 
internal genitalia. The left gonad seems to be more severely affected suggesting 
possible mechanisms in left/right asymmetry as in birds (Guioli and Lovell-Badge
2007) . The phenotype of rspol null mice is similar to WNT4 null mice suggesting 
that these genes act in the same molecular pathway. Rspol is required for the 
upregulation of WNT4 in XX gonads (Chassot, Gregoire et al. 2008).
Rspol also activates the p-catenin signalling pathway required for female somatic 
cell differentiation and germ cell commitment into meiosis (Chassot, Gregoire et al.
2008) .
1.4.8.4 Dosage Sensitive Sex Reversal, Adrenal Hypoplasia Congenital Critical 
Region on the X Chromosome Gene 1 (DAX1)
Originally DAX1 was considered to be an ovarian determining or anti testis gene as 
it is a SF1 and SRY antagonist (Iyer and McCabe 2004), but loss of function had no 
developmental consequences (Bardoni, Zanaria et al. 1994; Swain, Zanaria et al. 
1996).
1.4.8.5 Forkhead Box Gene L2 (FOXL2)
Despite their importance in female genital development neither dax1 or WNT4 has 
been proved to be the ovarian determining factor (Wilhelm, Palmer et al. 2007). 
Another possible candidate for this role is foxl2 which is expressed in a female 
specific manner in the gonads in mesenchymal pre-granulosa cells and then in 
granulosa cells. (Schmidt, Ovitt et al. 2004). However foxl2 null mutations do not 
result in early ovarian defects thus excluding foxl2 as the ovary determining factor 
(Schmidt, Ovitt et al. 2004; Uda, Ottolenghi et al. 2004).
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Kashmada and colleagues reported that fox!2 and bone morphogenic protein 2 
{bmp2) cooperate to regulate follistatin expression during ovarian development. 
Foxl2 null mice have reduced follistatin expression throughout fetal ovarian 
development and reduced b/r?p2 expression (Kashimada, Pelosi et al. 2011).
Foxl2 is the only female specific gene that is active continuously throughout female 
sex development and the foxl2 pathway both initiates and maintains sex 
differentiation in the somatic cells during this development (Ottolenghi, Uda et al. 
2007; Garcia-Ortiz, Pelosi et al. 2009). Loss of foxl2 and WNT4 lead to partial 
female to male sex reversal resulting in testis differentiation (Ottolenghi, Pelosi et al. 
2007).
1.4.8.6 Basic Helix Loop Helix (bHLH)
Pod-1 a basic helix loop helix transcription factor is required for correct ovarian 
development and as discussed previously the bipotential genital ridge is abnormal in 
pod-1 knockout mice with impaired vascular development (Cui, Ross et al. 2004).
1.4.9 Germ Cell Development
During the early development stages a germ cells fate rests on which differentiating 
gonad it resides. If it resides in an ovary it commits to oogenesis and enters 
meiosis. If it resides in the testes it commits to spermatogenesis and enters mitotic 
arrest until puberty (McLaren 1984; Rolland, Lehmann et al. 2010). Towards the end 
of the embryonic period both XX and XY germ cells are capable of meiosis, 
expressing ‘deleted in azoospermia-like’ (Dazl) which are RNA binding proteins 
involved in fertility (Lin, Gill et al. 2008).
Retinoic acid stimulates the onset of meiosis of germ cells in the ovary, at 13.5dpc 
in the mouse. The testes are prevented from developing germ cells initially by 
expressing a retinoic acid degrading enzyme CYP26 (Bowles, Knight et al. 2006; 
Koubova, Menke et al. 2006). For XY germ cells in the testes, to commit to the male 
pathway it appears necessary for there to be an absence of retinoic acid and may 
also rely on additional male specific factors. Sertoli cells express CYP26B1 which is 
a retinoic acid metabolizing enzyme and this reduces the exposure to retinoic acid 
(Rolland, Lehmann et al. 2010).
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1.5 Possible Association of Sex Determining Processes 
with Congenital Diaphragmatic Hernia
Approximately 30-40% of cases of congenital diaphragmatic hernia including 
pulmonary hypoplasia and pulmonary hypertension have additional major 
malformations including cardiovascular, gonadal, renal, skeletal, digestive system 
and central nervous system anomalies (Benjamin, Juul et al. 1988). There may be 
potential mechanisms underlying the seemingly random combination of 
diaphragmatic, pulmonary, cardiovascular, gonadal and other defects (Benjamin, 
Juul et al. 1988; Losty, Vanamo et al. 1998; van Dooren, Goemaere et al. 2004). In 
both animal models and humans a single gene defect can cause a global 
embryopathy, the result of a disruption of fundamental developmental processes 
during organogenesis. Congenital diaphragmatic hernia has been described as part 
of genetic syndromes (Slavotinek 2005) and also non-syndromic birth defects when 
a chromosomal or gene abnormality cannot be established. It is possible to 
hypothesise that a mutant gene as yet unidentified is responsible for the range of 
anomalies in these non-syndromic cases including congenital diaphragmatic hernia 
and disorders of sex development (Pober 2007).
In humans, mutations in SRY, SOX9, SF1, WT1 or DHH as well as duplications of 
DAX1 or WNT4 can disrupt the balanced network of gene expression causing XY 
gonadal dysgenesis or XY sex reversal (Fleming and Vilain 2005). These together 
explain 20% of the cases of disorders of sex development, as previously stated 
most cases remain unexplained implying that a number of sex determining genes 
remain undiscovered (Bagheri-Fam, Sim et al. 2008).
One mechanism for this embryopathy of diaphragmatic and extradiaphragmatic 
defects including disorders of sex development is a mesenchymal hit hypothesis. 
There are similar signalling pathways in all the affected organs and the function of 
the mesenchymal cells may be perturbed by environmental or genetic factors 
(Keijzer, Liu et al. 2000; Featherstone, Connell et al. 2006; Jesudason 2006; 
Jesudason, Smith et al. 2006). Germline mutations in transcription factors lead to 
impaired structural integrity and development of the affected organs. Several factors 
have been identified that have a multi organ developmental role including WT1, 
FGF9, Retinoids, FGFR2, FGF10, FOG2 and GATA4, (Lin, Tsai et al. 2010).
Correct dosage of fog2 and GATA4 transcription factors are required for fetal testes 
development in mice (Bouma, Affourtit et al. 2007; Bouma, Washburn et al. 2007).
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F0G2, a zinc fingered transcription factor is expressed in the embryonic diaphragm, 
lung mesenchyme, epicardium, myocardium and testicular somatic cells (Tevosian, 
Deconinck et al. 1999; Ketola, Anttonen et al. 2002). The FOG2 gene is on 
chromosome 8q23 and rearrangements on 8q22-23 have been observed in patients 
with congenital diaphragmatic hernia. Patients who are heterozygous for loss of 
function point mutations of FOG2 have diaphragm anomalies, (usually eventration), 
pulmonary hypoplasia, and may have cardiac anomalies (Ketola, Anttonen et al. 
2002; Anttonen, Ketola et al. 2003; Ackerman, Herron et al. 2005). Fog2 null mice 
also have male to female sex reversal (Tevosian, Albrecht et al. 2002; Ackerman, 
Herron et al. 2005). During the initiation program of testes development the primary 
function of SRY in mouse is impaired in the absence of fog2 (Tevosian, Albrecht et 
al. 2002).
GATA4, also a zinc fingered transcription factor, interacts with FOG2 during 
embryonic development and has also been implicated in congenital diaphragmatic 
hernia and associated anomalies. The human GATA4 gene is located on 
chromosome 8p23.1 and microdeletion of this region is a recurring finding in 
patients with congenital diaphragmatic hernia (Pecile, Petroni et al. 1990; Faivre, 
Morichon-Delvallez et al. 1998; Lurie 2003; Barber, Maloney et al. 2005; 
Shimokawa, Miyake et al. 2005). GATA4 and Fog2 interactions for normal 
organogenesis are confirmed by the fact that homozygous mice that have a GATA4 
mutation disrupting the GATA4 /fog2 interactions have male to female sex reversal 
as well as pulmonary and cardiac malformations (Tevosian, Albrecht et al. 2002; 
Barber, Maloney et al. 2005). Patients heterozygous for GATA4 loss of function 
mutation have cardiac malformations but it not known whether point mutations or 
small deletions can cause defects (Garg, Kathiriya et al. 2003; Okubo, Miyoshi et al. 
2004; Nemer, Fadlalah et al. 2006).
Basic helix loop helix proteins govern cell fate and differentiation in a variety of 
tissues. Subgroups of these factors have an essential role in the embryonic 
development of mesodermal tissue, and pod-1 was one of the first of these 
subgroups to be described. It was found to be expressed at sites of epithelial 
mesenchyme interaction in the developing kidney, lung, intestine and pancreas 
(Quaggin, Vanden Heuvel et al. 1998).
There are several syndromes which include congenital diaphragmatic hernia and 
disorders of sex development amongst its recognised features. In some of these
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syndromes the causative gene is known but in other cases the causative gene has 
yet to be discovered.
1.5.1 Syndromes with Features Including Disorders of Sex 
Development and Congenital Diaphragmatic Hernia
1.5.1.1 Denys Drash, Frazier, WAGR and Meacham Syndromes, Mutations in 
Wilms Tumour 1 gene
Wilms Tumour 1 (WT1), a zinc finger transcription factor, is the product of the Wilms 
tumour suppressor gene and expressed in the amuscular diaphragm, pleural and 
abdominal mesothelial cells, epicardium, testicular somatic cells and the developing 
kidney (Kreidberg, Sariola et al. 1993; Moore, Mclnnes et al. 1999; Natoli, Alberta et 
al. 2004). Heterozygous WT1 losses of function mutations cause a range of 
overlapping clinical syndromes for example Denys-Drash syndrome, Meacham 
syndrome, Frasier syndrome and WAGR (Wilms tumour-Aniridia-Genitourinary 
anomalies-Mental retardation). These syndromes have clinical features of 
congenital diaphragmatic hernia, cardiac malformations and genitourinary defects.
The WT1 gene has many isoforms that are critical for the formation of mesenchymal 
tissues, kidney and gonads. WT1 null mice have defects in the pleuroperitoneal fold 
(Clugston, Klattig et al. 2006) however not every case of Denys Drash or Frazier 
syndrome has a congenital diaphragmatic hernia. This indicates loss of function of 
WT1 is a predisposing factor but other factors, possibly genetic or environmental 
are required for the expression of the diaphragmatic defect (Little and Wells 1997).
1.5.1.2 Fryns Syndrome
The multiple developmental anomalies of Fryns syndrome were first described in 
1978 and 1979 (Fitch, Srolovitz et al. 1978; Fryns, Moerman et al. 1979). The 
features of Fryns syndrome include congenital diaphragmatic hernia, pulmonary 
hypoplasia, genitourinary anomalies, cardiovascular malformations and several 
other anomalies. Fryns syndrome is the most common multiple congenital anomaly 
syndrome associated with congenital diaphragmatic hernia and is thought to be 
inherited in an autosomal recessive manner (Slavotinek 2004; Gremeau, Coste et 
al. 2009).
The cause of Fryns Syndrome is at present unknown (Slavotinek 2004).
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1.5.1.3 Swyer Syndrome
Children with Swyer syndrome have XY gonadal dysgenesis. There is male to 
female sex reversal and occasionally congenital diaphragmatic hernia. The gene 
involved is at present unknown but this syndrome may be caused by a mutation or 
deletion of SRY as 30% of human Swyer syndrome cases have some mutation of 
the SRY gene. However these human cases with a mutation of the SRY gene do 
not include any cases in which a congenital diaphragmatic hernia is present (Pober, 
Russell et al. 1993).
1.5.1.4 CHARGE Syndrome
CHARGE is an acronym for a syndrome summarised by the main features, 
coloboma, heart defect, atresia chonae, retarded growth and development, genital 
anomalies and ear anomalies. Congenital diaphragmatic hernia is an occasional 
finding (Casaccia, Digilio et al. 2008).
A mutation on the Chromodomain-helicase-DNA-binding protein 7 {CHD7) gene 
located on chromosome 8 has been identified in a high number of CHARGE 
syndrome cases (Vissers, van Ravenswaaij et al. 2004; Lalani, Safiullah et al. 
2006). CHD7 is chromatin remodeler and is essential for the formation of migratory 
neural crest cells that give rise to many structures throughout the embryo. It is 
essential for activation of sox9 in the otic placode and neural crest (Bajpai, Chen et 
al. 2010) and thus could be necessary also in other organs as not yet identified. 
Kallman syndrome a mild variant of CHARGE syndrome is also caused by CHD7 
mutations but these mutations are less severe (Kim, Kurth et al. 2008).
1.5.1.5 Spondylocostal Dysostosis and Spondylothoric Dysplasia
Spondylocostal dysostosis is characterised by defective development of the axial 
skeleton with abnormal rib and spinal development, cardiac defects, vascular 
defects, disorders of sex development and in some cases congenital diaphragmatic 
hernia. It has been speculated that the cases of congenital diaphragmatic hernia 
may have been caused by the chest abnormalities interfering mechanically with 
diaphragm development (Slavotinek 2007).
All genes identified in cases of Spondylocostal dysostosis are involved in Notch 
signalling, early embryonic patterning and somite formation in the mouse (Bulman, 
Kusumi et al. 2000; Whittock, Ellard et al. 2004; Whittock, Sparrow et al. 2004;
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Sparrow, Chapman et al. 2006) but the expression of these genes in human somite 
formation has not been determined (Sparrow, Chapman et al. 2006).
Spondylothoric dysplasia has phenotypic similarities with Spondylocostal dysostosis 
but with a different rib maldevelopment, disorders of sex development, malformed 
vertebrae (Day and Fryer 2003) and congenital diaphragmatic hernia has been 
reported in some cases (Shehata, El-Banna et al. 2000). The genes involved in 
Spondylothoric dysplasia have not been identified and the diaphragmatic hernia 
may also be due to the chest abnormalities (Slavotinek 2007).
1.5.1.6 Craniofrontonasal Dysplasia
Craniofrontonasal dysplasia is caused by a mutation in the Ephrin B1 gene (Twigg, 
Kan et al. 2004; Wieland, Reardon et al. 2005) and is more severe in females. 
Ephrin B1 is involved in the migration of neural crest cells (Wieacker and Wieland 
2005).
Congenital diaphragmatic hernia and sacrococygeal teratoma, a germ cell tumour 
are features that may occur with Craniofrontonasal dysplasia (Vasudevan, Twigg et 
al. 2006).
1.5.1.7 Serkal Syndrome
A mutation in the WNT4 human gene is the cause of Serkal syndrome. This causes 
downregulation in the expression of WNT4 mRNA levels and thus affecting the 
many WNT4 pathways involved in human embryogenesis (Logan and Nusse 2004). 
WNT4 deficiency results in human female to male sex reversal and cases including 
congenital diaphragmatic have been reported (Mandel, Shemer et al. 2008) but the 
WNT4 deficient mouse has only partial sex reversal (Chassot, Ranc et al. 2008; 
Tomizuka, Horikoshi et al. 2008).
1.5.1.8 Cornelia- de-Lange Syndrome
Congenital diaphragmatic hernia is an uncommon but recognised clinical feature of 
Cornelia de Lange syndrome (Martinez-Frias, Bermejo et al. 1998; Slavotinek 
2007), caused by a mutation in the Nipped-B-like (NIPBL) gene. The NIPBL gene 
provides the codes for delangin, a protein which helps control the activity of 
chromosomes during cell division. Delangin is also involved in DNA repair and 
regulates the activity of some of the genes involved in development. This mutation
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leads to the production of a small non functioning version of delangin (Dorsett and 
Krantz 2009).
1.5.1.9 Turner syndrome
Turner syndrome is a condition in which a part of one of the X chromosomes is 
missing in females. Multiple anomalies are a feature of this syndrome which include 
gonadal dysgenesis and sometimes congenital diaphragmatic hernia (Cigdem, 
Onen et al. 2007).
1.5.1.10 Emanual syndrome
Emanuel syndrome is caused by a chromosome imbalance affecting chromosome 
22 (Zackai and Emanuel 1980). In most cases one of the parents is a carrier with a 
balanced defect on chromosome 22 and is phenotypicaly normal. This syndrome 
has multiple anomalies including mental retardation, ear, cardiac, renal, 
diaphragmatic, anal and genital anomalies in males (Zackai and Emanuel 1980). 
This syndrome was named Emanuel syndrome in 2004 and was previously reported 
as ‘partial trisomy 22’ or ‘partial trisomy 1T (Gremeau, Coste et al. 2009).
1.5.1.11 Simpson-Golabi-Behmel Syndrome
Simpson-Golabi-Behmel syndrome can affect many developing organs including the 
diaphragm and the genitourinary system (Iglesias, Centeno et al. 2008). Mutations 
of the glypican-3 gene (GPC3) which is involved in cell growth and proliferation are 
responsible for some cases of Simpson-Golabi-Behmel syndrome but other cases 
do not have identifiable mutations of the GPC3 gene and the cause of this anomaly 
is at present unidentified.
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1.6 Nitrofen, (2,4-dichloro-4’-nitrodiphynel ether)
1.6.1 Nitrofen Rat Model of Congenital Diaphragmatic Hernia
1.6.1.1 Suitability for research
Congenital diaphragmatic hernia is an abnormality affecting approximately 1 in 3000 
live births with considerable morbidity and mortality. The development of animal 
models has enabled the detailed study of congenital diaphragmatic hernia and 
accompanying anomalies. In particular the nitrofen model has greatly increased our 
understanding of the development of this anomaly.
Nitrofen, (2,4-dichloro-4’“nitrodiphynel ether) is a toxic herbicide that was first 
reported by toxicologists in 1971 to cause congenital anomalies in rodents following 
oral administration to pregnant rodents, (for example skeletal, craniofacial, renal, 
cardiac, pulmonary and congenital diaphragmatic hernia). The developing lung 
anlage, heart and diaphragm are believed to be the principle target sites for nitrofen 
induced malformations (Ambrose, Larson et al. 1971; Costlow and Manson 1981; 
Nakao, Miura et al. 1981; Lau, Cameron et al. 1988; Kluth, Kangah et al. 1990; 
Kluth, Tenbrinck et al. 1993; Wickman, Siebert et al. 1993). These malformations 
are induced at an early embryonic stage of development in rodents and are 
strikingly similar to the pattern of anomalies associated with congenital 
diaphragmatic hernia in humans (Sweed and Puri 1993; Fauza and Wilson 1994; 
Losty, Connell et al. 1999). These results support the use of this animal model in the 
study the pathogenesis of congenital diaphragmatic hernia. Environmental agents 
have been implicated in the aetiology of human malformations.
1.6.1.2 Toxicology of Nitrofen
Toxicology studies have demonstrated that the teratogenicity of nitrofen is dose 
dependent and its effects are variable depending on the gestational age of the 
embryo. In the case of the rat model the most susceptible age for dosing of the 
dam to create congenital diaphragmatic hernia is between 9dpc and 11dpc, (term = 
day22), (Manson JM 1986, Costlow R 1981, Kluth D 1990, Tenbrinck R 1990). 
Maternal dosing by gavage on day 9.5dpc produces mostly left sided congenital 
diaphragmatic hernia, whilst dosing 10-11dpc produces mostly right sided 
congenital diaphragmatic hernia, (Kluth, Kangah et al. 1990). Dosing with nitrofen at 
9.5dpc to create mainly left sided congenital diaphragmatic hernia corresponds 
closely with the time 24 hours before the lung anlage branches from the
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oesophagus. Dosing at 11.5dpc is 24 hours after the primitive lung bud has 
developed and undergoing early development creates mainly right sided congenital 
diaphragmatic hernia. The optimum dosage of nitrofen chosen by Kluth and 
colleagues (Kluth, Kangah et al. 1990) to induce congenital diaphragmatic hernia in 
rat embryos was 100mg. During the period of susceptibility to nitrofen administration 
in the rat model (9 - 11dpc) there is a reduction in retinol levels in the rat due to 
increases in retinol utilisation (Takahashi, Smith et al. 1977). This may leave the 
embryo susceptible to perturbations of retinoid levels or function during this period. 
Also the developing lung which expresses retinal dehydrogenase and relies on 
retinoid mediated signalling for proper development (Malpel, Mendelsohn et al. 
2000) is also compromised by nitrofen (Jesudason, Connell et al. 2000; Keijzer, Liu 
et al. 2000; Acosta, Thebaud et al. 2001).
1.6.1.3 The Nitrofen Molecule (C12H7CI2NO3)
Nitrofen is a structural analogue of thyroid hormones T3 and T4 (tridothyronin and 
thyroxine). It was believed to exert its teratogenic effects on maternal and or fetal 
thyroid hormone metabolism (Gray, Kavlock et al. 1982; Manson 1986). However 
more recently it is considered that nitrofen has no substantial role in the 
perturbations of thyroid hormone signaling or receptor function (Noble, Babiuk et al. 
2007).
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Figure 4 Nitrofen and thyroid hormone molecules
Administering radio labelled nitrofen to pregnant rats demonstrated that only 1-5% 
of the product crosses the placenta. Radioactivity is detected in embryonic rat 
tissues within three hours of gavage administration to the dam reaching its 
maximum concentration at 72 hours. Nitrofen is degraded to hydroxylation, 
nitroreduction and acetylation products. In the embryo only the native nitrofen can 
be detected, therefore intermediate metabolites do not by themselves exert any 
teratogenic potential on the embryo (Manson JM 1986).
1.6.2 Impact of Nitrofen on the Molecular Processes of Development in 
the Rat Model of Congenital Diaphragmatic Hernia
1.6.2.1 Impact of Nitrofen on the Retinoic Acid Pathway
Nitrofen suppresses the action of retinaldehyde dehydrogenase-2, the key enzyme 
involved in retinoic acid production (Greer, Cote et al. 2000; Greer, Babiuk et al. 
2003). The administration of retinoic acid to pregnant rats reduces the incidence of 
teratogenic effects of nitrofen on the diaphragm lung, thymus and heart (Thebaud,
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Tibboel et al. 1999; Thebaud, Barlier-Mur et al. 2001; Yu, Gonzalez et al. 2002; 
Babiuk, Thebaud et al. 2004).
Genes associated with the retinoic acid pathway including Chicken ovalbumin 
upstream promoter-transcription factor 11 (COUP-TF11), GATA binding protein 4 
(GATA4) and friend of GALA 2 (FOG2). These genes are all located on an area of 
chromosome that is disrupted in some cases of congenital diaphragmatic hernia, (a 
chromosomal ‘hot spot’ for congenital diaphragmatic hernia) (Doi, Sugimoto et al. 
2009). It is speculated that the expression of these factors is altered after nitrofen 
exposure disrupting downstream genes in lung and diaphragm development (Doi, 
Sugimoto et al. 2009). The pulmonary gene expression of coup~tf11 is upregulated 
in the early stages of development, 9.5dpc to 15dpc, of the nitrofen induced 
hypoplastic rat lung and this increased expression of coup-tf11 may inhibit the 
retinoid signaling pathway (Doi, Sugimoto et al. 2009). Also treating pregnant 
nitrofen exposed rats with retinoic acid upregulates the pulmonary gene expression 
of coup-tfH, GATA4, and fog2 in the offspring, but did not increase the expression 
of these genes in non nitrofen exposed offspring. This suggests that retinoic acid 
may have a role in modulating lung growth (Doi, Sugimoto et al. 2009).
Wilms tumour gene 1 (WT1) is also involved in the retinoid signaling pathway. 
Dingeman and colleagues provided evidence that WT1 expression is reduced in 
nitrofen exposed rat fetuses. It is significantly downregulated in the pleuroperitoneal 
fold at 13dpc and in the developing diaphragm at 18 and 21dpc (Dingemann, Doi et 
al. 2011).
1.6.2.2 Impact of Nitrofen on the Myogenic Factors Involved in Diaphragm 
Development
Myogenic differentiation 1 (MyoD) and myogenic factor 5 (Myf5) have a critical role 
in muscularisation and mutants of MyoD have a reduced size diaphragm (Inanlou, 
Dhillon et al. 2003). However Myf5 mutants do not have diaphragmatic defects. In 
the nitrofen exposed fetuses MyoD gene expression was reduced during the 
muscularisation process of diaphragm formation impairing the migration and 
proliferation of the muscle precursor cells (Dingemann, Doi et al. 2011).
1.6.2.3 Impact of Nitrofen on Heparan Sulphate Proteoglycans
Nitrofen has been shown to cause abnormalities in heparan sulphate fine structures 
and spatiotemporal distribution of heparan sulphate epitopes in the hypoplastic 
lungs of the nitrofen rat model of congenital diaphragmatic hernia. Fibroblast growth
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factors (FGF)s are essential for lung morphogenesis, particularly FGF2, FGF9 and 
FGF10 and require heparan sulphate for receptor activation and subsequent 
signalling (Rapraeger, Krufka et al. 1991; Yayon, Klagsbrun et al. 1991; Ornitz, 
Yayon et al. 1992). The changes in the heparan sulphate structures were identified 
as those recognised by FGF2 and FGF9 (Thompson, Connell et al. 2011).
1.6.2.4 Impact of Nitrofen on Wingless-Related MMTV Integration Site Famiiy 
Members (WNT)
The expression of several of the Wingless-Related MMTV Integration Site Family 
Members (wnt) is altered in the offspring of nitrofen exposed dams. The gene 
expression of wnt5 is upregulated in the lungs of nitrofen exposed offspring during 
the mid to late stages of lung development (Doi and Puri 2009). Wnt5 regulates 
sonic hedgehog (Shh), bone morphogenic protein 4 (bmp4) and fgf10 expression in 
the developing lung and the upregulation of wntS reduces the expression of 
particularly fgf10 leading to reduced branching morphogenesis and pulmonary 
hypoplasia (Bellusci, Grindley et al. 1997; Cardoso, Itoh et al. 1997). Also wnt2 and 
wnt7 gene expression is downregulated in nitrofen exposed fetuses, both these 
genes are also involved with branching morphogenesis (Takayasu, Murphy et al. 
2010).
1.6.2.5 Impact of Nitrofen on Fibroblast Growth Factors and their Receptors
Fibroblast growth factor receptor-like 1 is downregulated in the nitrofen model of 
congenital diaphragmatic hernia and this may contribute to the diaphragmatic defect 
in the nitrofen model (Dingemann, Doi et al. 2010; Dingemann, Doi et al. 2011).
Fibroblast growth factors 10 and 7 are also downregulated in the nitrofen model of 
congenital diaphragmatic hernia (Teramoto, Yoneda et al. 2003). Fgf10 is critical 
for branching morphogenesis at the lung bud tip (Park, Miranda et al. 1998) as 
discussed in the previous section interacting with Shh and bmp4 regulated by wnt5 
(Bellusci, Grindley et al. 1997; Cardoso, Itoh et al. 1997).
1.6.2.6 Impact of Nitrofen on Insulin Like Growth Factors, Receptors and 
Binding Proteins 3, 4 and 5
As previously discussed Insulin-like growth factor family is essential for lung 
development. They are involved with DNA synthesis, cell differentiation and survival 
(Rubin and Baserga 1995).
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The gene expression of insulin-like growth factor binding proteins (IGFBP) 3 and 5 
are downregulated in nitrofen induced pulmonary hypoplasia and may play a role in 
the development of the pulmonary hypoplasia by interfering with the retinoid 
signaling pathway (Dingemann, Doi et al. 2010; Ruttenstock, Doi et al. 2011; 
Ruttenstock, Doi et al. 2011). Insulin-like growth factor receptors 1 and 2 are 
downregulated in this model particularly on 21dpc in the rat nitrofen model, a critical 
time for alveogenesis (Ruttenstock, Doi et al. 2010). It can however be upregulated 
by prenatal administration of retinoic acid indicating that retinoic acid may promote 
lung growth by stimulating insulin like growth factor receptor mediated 
alveologenesis (Ruttenstock, Doi et al. 2011).
The insulin like receptor gene and protein expression is involved in surfactant 
synthesis (Felts 1964), and these are downregulated in the rat nitrofen model of 
congenital diaphragmatic hernia. This may interfere with normal surfactant synthesis 
during the later stages of lung development contributing to the pulmonary 
hypoplasia (Ruttenstock, Doi et al. 2010).
Overexpression of IGFBP4 is reported in the nitrofen exposed fetal lungs during the 
later stages of development and may contribute to the pulmonary hypoplasia by 
inhibiting insulin like growth factor mediated cell proliferation (Ruttenstock, Doi et al. 
2011).
1.6.2.7 Impact of Nitrofen on Slit2 and Slit3
Slit2 and Slit3 and have a role in the differentiation and organisation of lung 
mesenchyme during branching morphogenesis and vasculargenesis (Greenberg, 
Thompson et al. 2004). Slit2 and Slit3 gene expression is upregulated in the 
nitrofen model of congenital diaphragmatic hernia and Doi and colleagues 
hypothesised that this would disrupt the organisation and differentiation of 
pulmonary mesenchyme leading to pulmonary hypoplasia (Doi, Hajduk et al. 2009).
1.6.2.8 Impact of Nitrofen on Parathyroid Hormone Signaling
Nitrofen downregulates the gene expression of parathyroid hormone in the nitrofen 
exposed fetus inhibiting the related protein signalling disrupting alveolar maturation 
and surfactant production (Doi, Lukosiute et al. 2010; Doi, Sugimoto et al. 2011). 
This downregulation of parathyroid hormone expression can be upregulated by 
treatment with retinoic acid in the lungs of the offspring of nitrofen exposed dams 
stimulating alveolar maturation and surfactant production (Doi, Sugimoto et al. 
2011).
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1.6.2.9 Impact of Nitrofen on Vascular Endothelial Growth Factor, Endothelin 1 
and Endothelin Receptors A and B
Endothelin 1 is produced in vascular endothelial cells and affects vascular smooth 
muscle cells acting through its receptors, endothelin receptors A and B (EDNRA 
and EDNRB) (Boscoe, Goodwin et al. 2000) which control vasoconstriction, 
vasodilation and regulate vascular smooth muscle proliferation (Michael and 
Markewitz 1996; McCulloch, Docherty et al. 1998; Okazaki, Sharma et al. 1998). In 
the nitrofen induced hypoplastic lung the expression of EDNRA and EDNRB are 
upregulated leading to the pulmonary arteries becoming excessively muscularised 
therefore causing pulmonary hypertension (Dingemann, Doi et al. 2010).
Vascular endothelial growth factor (VEGF) also plays a key role in the development 
of the pulmonary vasculature (Shifren, Doldi et al. 1994; Patan 2000) and is 
downregulated in nitrofen induced congenital diaphragmatic hernia (Chinoy, Graybill 
et al. 2002; Chang, Andreoli et al. 2004). VEGF added to lung buds in culture from 
nitrofen exposed offspring and normal offspring accelerated airway branching 
(Shinkai, Shinkai et al. 2006).
1.6.2.10 Impact of Nitrofen on Sonic Hedgehog
Sonic hedgehog (shh) is essential for lung development and branching 
morphogenesis and its expression was reported to be unaltered in one report of 
nitrofen exposed offspring (Sato, Murphy et al. 2009). Previously Unger and 
colleagues reported that shh expression in nitrofen exposed offspring was initially 
downregulated and its expression peaked at a later stage than in non nitrofen 
exposed offspring (Unger, Copland et al. 2003). Shh was also seen to inhibit fetal 
lung fibroblasts in vitro therefore also interfering with extra cellular matrix formation 
(Unger, Copland et al. 2003).
1.6.2.11 Impact of Nitrofen on Extra Cellular Matrix Proteins
Lungs of mice with deleted retinoic acid receptor have reduced elastin content 
(McGowan, Jackson et al. 2000) and pulmonary elastin expression is reduced and 
the elastic fibres disorganised in the lungs of offspring of nitrofen exposed dams. 
The expression of elastin appears to be regulated transcriptionaly and the altered 
mechanical forces of the nitrofen model may have a role in the elastin anomalies 
(Mychaliska, Officer et al. 2004). The lungs of this model also had increased 
expression of tropoelastin and procollagen 1 leading to decreased compliance in the 
lung (Taira, Oue et al. 1999).
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1.6.3 Impact of Nitrofen on Diaphragmatic Development
The pleuroperitoneal fold has become a focus of attention for studies into the 
pathogenesis of congenital diaphragmatic hernia in the rat nitrofen model. The 
pleuroperitoneal fold is a pyramid shaped tissue that extends medially from the 
lateral cervical wall to the oesophageal mesentery and fuses ventrally with the 
septum transversum. The substructure of the pleuroperitoneal fold is derived from 
mesenchymal cells migrating from the somatic mesoderm, followed by muscle 
precursors migrating from the dermomyotome of cervical somites following 
guidance clues provided by the somatopleure substructure (Greer, Cote et al. 
2000). Greer and colleagues generated 3D reconstructions of the pleuroperitoneal 
fold of control and nitrofen exposed 13.5dpc rat embryos. They showed that in both 
left and right sided defects the malformations were always limited to the dorsolateral 
portions of the caudal regions of the pleuroperitoneal fold. This accounts for the fact 
that the diaphragmatic defects in nitrofen models are located in the dorsolateral 
regions on either the left side, right side or both sides (Greer, Babiuk et al. 2003).
The pleuroperitoneal fold in nitrofen exposed rats only showed gross abnormalities 
at 13 to 13.5dpc but the contribution of muscle precursors and the phrenic nerve 
were largely preserved in the abnormal pleuroperitoneal fold of nitrofen exposed 
embryos. This is consistent with the hypothesis that the pleuroperitoneal fold 
abnormalities arise from a defect in the nonmuscular mesenchyme of the 
pleuroperitoneal fold (Babiuk and Greer 2002). The muscle precursors in the 
developing diaphragm and the pleuroperitoneal fold of normal and nitrofen exposed 
embryos were tracked and muscle precursors appear to congregate, proliferate and 
differentiate normally in animals with diaphragmatic defects. There is a lack of 
regions of an underlying mesenchymal substratum in the pleuroperitoneal fold of the 
nitrofen exposed embryos (Babiuk and Greer 2002). This subsequently contributes 
to the defective herniated region thus this is consistent with the hypothesis that the 
underlying amuscular component specific to the diaphragmatic anlagen is defective 
in congenital diaphragmatic hernia. Babiuk and colleagues treated their c-met null 
mice, discussed previously, with the teratogens nitrofen and bis-diamine (also 
known to cause diaphragmatic defects) causing a defect in the mesenchymal 
scaffold also adding to the hypothesis that in congenital diaphragmatic hernia it is 
the membranous scaffold that is defective (Babiuk and Greer 2002). As there is no 
malregulation of myogenesis of the diaphragmatic muscle this explains why 
diaphragmatic muscle is affected but other skeletal muscle is not and also explains 
the muscular rim observed surrounding the diaphragmatic defect. Nitrofen exposed
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rats have decreased rates of celt proliferation in the pleuroperitoneal fold, indicating 
this to be a primary mechanism of nitrofen teratogenesis leading to abnormal 
pleuroperitoneal fold development leading to congenital diaphragmatic hernia 
(Clugston, Zhang et al. 2010).
1.6.4 Impact of Nitrofen on the Lung
Newborns with congenital diaphragmatic hernia have a high mortality rate mainly 
caused by pulmonary hypoplasia and pulmonary hypertension. Lung hypoplasia had 
traditionally been considered a consequence of the diaphragmatic hernia due to 
compression of the lungs by the abdominal organs that had herniated into the 
thoracic cavity (Harrison, Bressack et al. 1980; Harrison, Jester et al. 1980) or that 
there was growth competition between the lung and the herniated liver (Kluth, 
Tenbrinck et al. 1993). With the advent of the nitrofen rat model of congenital 
diaphragmatic hernia model this causal relationship had to be reappraised as there 
were pulmonary abnormalities before the development of the diaphragm (Iritani 
1984; Kluth, Tenbrinck et al. 1993; Jesudason, Connell et al. 2000).
As discussed previously the correct cascade of signals is required for initial lung bud 
formation followed by the development of the lung itself. Nitrofen is given to rats at 
day 9.5dpc in the case of this study, to create mainly left sided congenital 
diaphragmatic hernia at a time preceding foregut or lung development and therefore 
nitrofen has the potential to interfere with early growth and transcription factors 
(Whitsett 1998; Warburton and Lee 1999; Warburton, Zhao et al. 1999). Thus the 
nitrofen model enables the investigation of congenital diaphragmatic hernia before 
diaphragmatic abnormalities and this system therefore may be used to screen 
promoters of early pulmonary growth (Kluth, Kangah et al. 1990; Kluth, Tenbrinck et 
al. 1993; Kluth, Keijzeretal. 1996).
During the period of susceptibility to nitrofen administration in the rat model (9 - 
11dpc) there is a reduction in retinol levels in the rat due to increases in retinol 
utilisation (Takahashi, Smith et al. 1977). This may leave the embryo susceptible to 
perturbations of retinoid levels or function during this period. Also the developing 
lung which expresses retinal dehydrogenase-2 and relies on retinoid mediated 
signalling for proper development (Malpel, Mendelsohn et al. 2000) is also 
compromised by nitrofen (Jesudason, Connell et al. 2000; Keijzer, Liu et al. 2000; 
Acosta, Thebaud et al. 2001). As previously discussed human cases of congenital
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diaphragmatic hernia have also been shown to have reduced retinoid levels 
(Beurskens, Tibboel et al. 2010).
1.6.4.1 Lung Growth and Branching Morphogenesis
Using a terminal bud count as a measurement of branching morphogenesis in 
control and nitrofen rat lungs Jesudason and colleagues found that the nitrofen 
exposed lungs had a significantly reduced number of buds. A significant number of 
the nitrofen exposed lungs (36%) had an even more diminished lobar bronchi. This 
incidence of further stunted growth parallels the incidence of left sided congenital 
diaphragmatic hernia in this rat nitrofen model of congenital diaphragmatic hernia. 
They proposed that this dramatic disturbance of basic airway patterning specifically 
identified those embryos that would have developed a congenital diaphragmatic 
hernia (Jesudason, Connell et al. 2000). Fibroblast growth factors (FGF)s 1 and 2 
added to culture media of control and nitrofen lungs demonstrated different effects 
on growth and branching. Normal 13.5dpc embryonic lungs cultured with FGF1 
showed enhanced growth but nitrofen exposed lungs showed decreased growth in 
the presence of FGF1. Conversely FGF2 had minimal effect on the growth of 
normal lungs but the nitrofen exposed lungs showed an increase in lung area and 
the lungs were cystic and dilated (Jesudason, Connell et al. 2000).
1.6.4.2 Lung Growth and Cell Proliferation
Apoptosis and proliferation studies were performed in nitrofen exposed rat embryos 
from 13.5dpc until 16.5dpc. High levels of proliferation are detected in both normal 
and nitrofen exposed lungs at 13,5dpc but by 15.5dpc the nitrofen exposed lungs 
had a significant reduction in proliferation. This reduction was proportionately higher 
in the mesenchyme than in the airway epithelium (unpublished data). Both control 
and nitrofen exposed lungs showed low levels of apoptosis comparable to murine 
studies (Litingtung, Lei et al. 1998; Motoyama, Liu et al. 1998; Jesudason, Connell 
et al. 2000). These studies showed that reduced proliferation may play a role in lung 
hypoplasia in the nitrofen model of congenital diaphragmatic hernia, increased 
apoptosis in the lung does not (Jesudason, Connell et al. 2000). Enhanced 
apoptosis in the cervical somites of nitrofen exposed rat embryos has been 
implicated as a mechanism for diaphragmatic maldevelopment (Alles, Losty et al. 
1995). However with the somatic cell death in the cervical somites of nitrofen 
exposed rat embryos at 10.5dpc it remains possible that this enhanced apoptosis 
may induce embryonic lung hypoplasia by the removal of precursor cells earlier in 
development (Alles, Losty et al. 1995; Jesudason, Connell et al. 2000).
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1.6.4.3 Lung Growth, Peristalsis and Fetal Breathing Movements
Prenatal airways from diverse species are capable of spontaneous peristaltic 
contractions in each trimester and were observed in chick and guinea pig over 80 
years ago, reported by Lewis in the American Journal of Physiology in 1924. Airway 
smooth muscle has been described as the ‘appendix of the lung’ considered an 
evolutionary remnant that could cause lung disease in the future (Mitzner 2004). 
Another view suggests that airway smooth muscle is important in mammalian lung 
development driving airway peristalsis (Schittny, Miserocchi et al. 2000; 
Featherstone, Connell et al. 2006; Jesudason, Smith et al. 2006). The airway 
contractions produce intraluminal fluid flux in the developing lung distending the 
terminal buds of the lung and mechanical factors are known to regulate diverse 
aspects of morphogenesis including pre and postnatal lung development.
Airway smooth muscle dysfunction has been identified in the nitrofen model of 
congenital diaphragmatic hernia and pulmonary hypoplasia (Belik, Davidge et al. 
2003). The contraction of airway smooth muscle cells is propagated by spontaneous 
calcium waves (Featherstone, Jesudason et al. 2005). In the nitrofen model of 
congenital diaphragmatic hernia the airway smooth muscle calcium transients were 
abnormal at an embryonic stage before diaphragmatic development leading to 
abnormal peristaltic patterns (Featherstone, Connell et al. 2006).
1.6.5 Impact of Nitrofen on Different Organs
1.6.5.1 Impact of Nitrofen on Cardiac Development
Cardiac anomalies are the most common associated defect in infants with 
congenita! diaphragmatic hernia (Fauza and Wilson 1994) and are observed in the 
nitrofen rat model of congenital diaphragmatic hernia (Losty, Connell et al. 1999; 
Migliazza, Otten et al. 1999). The heart, lung and diaphragm may be particularly 
susceptible to nitrofen as the safety margin for retinoic acid mediated regulation of 
these organs is relatively low and thus more susceptible to perturbations than some 
other organs.
GATA4 function is first required in the visceral endoderm for normal heart 
development (Fleikinheimo, Ermolaeva et al. 1997; Narita, Bielinska et al. 1997) and 
GATA4 and its coregulator GATA6 are downregulated in the hearts of nitrofen 
exposed embryos, also reduced were their target genes wnt2, bmp4 and Myocyte 
specific enhancer factor 2c a gene involved in cardiac morphogenesis, myogenesis
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and vascular development (Bi, Drake et al. 1999; Takayasu, Sato et al. 2008). 
GATA4 has been reported to be regulated by retinoic acid signalling in 
cardiogenesis (Kostetskii, Jiang et al. 1999) and the nitrofen mediated perturbed 
retinoic acid and GATA4 expression may contribute to the cardiac maldevelopment 
(Takayasu, Sato et al. 2008).
1.6.5.2 Impact of Nitrofen on Renal Development
There is considered to be an association between renal hypoplasia, lung hypoplasia 
and congenital diaphragmatic hernia (Glick, Siebert et al. 1990; Hosoda, Rossman 
et al. 1993). The kidneys in the nitrofen model of congenital diaphragmatic hernia 
have been found to be hypoplastic and this was the result of altered rennin- 
angiotensin system gene expression (Chertin, Nakazawa et al. 2006; Montedonico, 
Nakazawa et al. 2007). However, Montedonico and colleagues also found kidney 
weights and retinol expression reduced in this model but disputed the association 
between renal and lung hypoplasia reported by Glick (Hosoda, Rossman et al. 
1993). Retinoids control kidney development through Ret expression (Gilbert 2002) 
and they suggested that nitrofen interfered with the retinoid pathway in kidney 
development and that the concentration of retinol is reduced in these kidneys 
(Montedonico, Nakazawa et al. 2007).
1.6.5.3 Impact of Nitrofen on Enteric Development
Intestinal rotation is often seen in human cases of congenital diaphragmatic hernia 
and it is assumed that this is caused by the abnormal thoraco-abdominal space that 
distorts the positioning of the gut during the reintegration of the umbilical hernia. The 
presence of a congenital diaphragmatic hernia increased the incidence of intestinal 
mairotation in the nitrofen model (Berman, Stringer et al. 1988; Baoquan, Diez- 
Pardo et al. 1995).
1.6.5.4 Impact of Nitrofen on Skeletal Development
Newborn human infants born with congenital diaphragmatic hernia may have a 
cluster of anomalies including skeletal defects. In a study by Migaliazza and 
colleagues to study the skeleton of the nitrofen exposed fetus they found 
abnormalities of the vertebrae, ribs and sternum (Migliazza, Xia et al. 1999) similar 
to those found in human cases.
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CHAPTER 2
Hypothesis, Aims and Methods
2.1 Hypothesis and Aims
Human studies note disorders of sex development and sex differences in the 
incidence of congenital diaphragmatic hernia. Nitrofen is a teratogen that produces 
experimental congenital diaphragmatic hernia in rodents. The action of nitrofen has 
been speculated to perturb the retinoic acid pathway. Transcription factors linked to 
the retinoic acid pathway are involved with sexual differentiation.
This study was designed to test the hypothesis that nitrofen may influence the 
sexual phenotype and frequency of congenital diaphragmatic hernia in the rat 
model.
2.2 Methods
2.2.1 Purchase and Housing
Sexually mature Sprague Dawley female rats (dams) and male rats (seven to nine 
weeks) were purchased from Charles River UK Ltd and kept in standard conditions 
and fed a standard diet with permanent access to food and drinking water. These 
formed the basis of a breeding colony. The rats were weighed at regular intervals 
and prior to mating.
2.2.2 Experimental Methods
Sprague Dawley rats were mated overnight in wire bottomed cages, one male and 
one female to a cage. The presence of a vaginal plug the following morning 
indicating positive pregnancy and recorded as day zero. Full term of pregnancy of 
Sprague Dawley rats was considered to be 22 days. The dams, both those with 
identifiable vaginal plug and also those with no detectable plug were regularly 
weighed during the next days to check for expected weight gain results. 
Occasionally a dam without a detectable vaginal plug would be pregnant and a dam 
with a vaginal plug would not be pregnant. This was an infrequent occurrence but 
was checked for. Pregnant rats were kept two or three to a cage using one, two or 
three bands drawn round the tail with a permanent marker pen to differentiate 
individuals.
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All procedures involving nitrofen were performed in a fume cupboard wearing 
protective equipment, gloves, face-mask and laboratory coat.
The concentration of nitrofen for dosing of rats was made up to 50milligrams (mg) 
nitrofen (Zhejiang Chemicals, Peoples Republic of China) dissolved in 1 millilitre (ml) 
of olive oil.
The nitrofen solution was made by dissolving nitrofen into olive oil. To make 50ml of 
nitrofen solution, nitrofen (weight 2.5 grams) was added to about 20 mis of olive oil 
in a Schott 100 ml bottle and then the volume made up to 50 mis with olive oil. This 
was dissolved by placing the bottle of olive oil and nitrofen in a water bath on a 
heater stirrer and heating to 70°C stirring continuously until the nitrofen was 
dissolved. This was then cooled and labelled with the appropriate safety labels for 
mutatagen. The dissolved nitrofen was then kept at the Biomedical Services Unit in 
a fume hood which was also used for the dosing of pregnant dams.
Pregnant dams were gavage fed 2ml of the nitrofen solution on day 9.5 of gestation 
in the fume hood, this giving a dose of 100mg nitrofen dissolved in 2ml of olive oil. 
This was to produce predominantly left sided congenital diaphragmatic hernia. 
Controls (non nitrofen fed dams) were utilized for all comparative analysis. The 
nitrofen dosed dams were then kept in filter cages in a separate room. All waste 
bedding was double bagged and incinerated. A total of 39 nitrofen exposed 
pregnant dams were used for this study.
At day 20 or 21 of gestation pregnant dams were euthanized by an abdominal 
injection of pentabarbitone. The uterus was exposed and opened along its horns by 
cutting carefully with a pair of spring loaded scissors and was examined for 
evidence of fetal resorptions indicated by an area of blood stained clot of tissue. The 
fetuses were then recovered by opening the sac, exposing the fetal abdomen and 
giving an abdominal injection of pentabarbitone to confirm loss of life. The fetuses 
were then removed from the uterus by cutting the umbilicus.
All procedures were performed in accordance with UK Home Office legislation and 
regulations.
2.2.3 Photography
All photography was done using a Leica DFC300 digital camera mounted on a Leica 
WILD M8 stereo microscope. Lighting was from a Schott fibre optic light source.
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Specimens were placed on thick black cotton velvet for photography to obtain a non 
reflective black background.
2.2.4 Examination of External Genitalia
The external genitalia of each pup were examined to determine sexual phenotype. 
The distance between the anus and genital organ was measured and studied. In 
females the distance between the anus and genital organ was shorter than in 
males. The males also had a crease in the perineum, the tissue between the anus 
and genital organ.
To photograph the external genitalia the fetuses were placed head down in a small 
beaker lined with black velvet for support and the tail held away using forceps 
exposing the external genitalia.
2.2.5 Examination of Internal Genitalia
To examine the internal genitalia of the fetuses they were pinned down on a cork 
board, pins holding the limbs and head clear of the abdomen and thorax.
The abdomen was opened using small springbow dissecting scissors (TAAB 
laboratories catalogue number S213). Starting at the umbilical cord cutting towards 
the pelvic region and then cutting towards the thorax being very careful to not cut 
sufficiently high to damage the diaphragm.
Using the curved edge of curved fine forceps TAAB laboratories fine tweezers 
number 7, the liver and gastro-intestinal tract was carefully removed to reveal the 
internal genito-urinary system and the diaphragm. Special care was needed to avoid 
damage to the ovaries as these were tucked behind the kidneys. Organs that had 
penetrated the thoracic cavity through the diaphragmatic hernia were carefully 
extracted exposing the thoracic cavity area that had been occupied by them. The 
liver was usually the organ that had invaded the thoracic cavity in all the different 
types of hernia observed. By using the curve of the forceps it avoided possible 
damage to the diaphragm from the points of the tweezers.
Internal genitalia were examined for the presence/absence of testes, ovaries and 
uterus with fallopian tubes. Findings of internal genitalia were checked with the 
findings of external genitalia for correlation.
For photographing the internal genitalia the fetuses were just laid on black velvet 
after the internal genitalia had been exposed.
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2.2.6 Examination of the Diaphragm
The diaphragm was examined from the abdominal side and the site and position of 
a hernia was recorded if present or complete diaphragm examined.
Specimens were fixed in 10% buffered formalin and archived for photography. To 
obtain photographs of the abdominal surface of the diaphragm the abdominal 
organs were removed and the body wail was cut away to allow a clear view of the 
diaphragm and then the fetus was also placed head down in a small beaker lined 
with the black velvet to support it.
2.2.7 Recording of Results
All results from the examination of external and internal genitalia to define gender 
and from the examination of the diaphragm were recorded on a Microsoft excel 
spreadsheet.
Three separate tables were drawn from these results for analysis and a graph 
showing diaphragm morphology detailed below.
1 Table of gender and absence or presence and type of a hernia in nitrofen 
exposed offspring.
2 Table of results given as a percentage of the diaphragm examination of 
nitrofen exposed offspring.
3 Table of total numbers of hernias in nitrofen exposed offspring.
4 Graph of hernia distribution given as a percentage.
2.2.8 Statistics
The potential difference between susceptibility to congenital diaphragmatic hernia in 
male and female offspring of nitrofen exposed rat dams was calculated by two 
methods:-
1) Chi-squared test.
2) Odds ratio.
Both are recognised methods for analysing binomial discrete data.
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CHAPTER 3
Results
3.1 Overview
In all Nitrofen exposed pups (n=518) internal and external genitalia concorded 
without evidence of significant genital tract malformations or intersex anomalies. For 
control non nitrofen exposed pups (n=300) diaphragm and genitalia were examined 
and no anomalies were found. To add to the figures for sex distribution the birth 
figures from the breeding colony were added to the total (n=300) By including the 
breeding colony figures an accurate figure of sex distribution could be obtained and 
this was an equal number of male and female pups. There was no evidence of 
excess foetal loss (i.e. prenatal resorptions) of either sex after nitrofen exposure as 
the ratios of male to female pups matched the control birth population.
Tables of distribution of diaphragmatic findings were created showing the numbers 
of nitrofen exposed fetuses and diaphragmatic defects in male and female offspring 
and graph of congenital diaphragmatic hernia distribution.
3.2 Gender
We were able to examine the external and internal genitalia in all the rat fetuses 
delivered from the dams. The morphology of the external genitalia was clearly 
defined in all cases. The internal genital morphology was also clearly defined and 
confirmed the findings of the external genitalia in all cases.
The following images show the morphology of the male and female external and 
internal genitalia.
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3.3 External Genitalia of Male and Female 21dpc Rat Fetus
Figure 5 Male external genitalia
Figure 5
External genitalia of a 21dpc male 
rat fetus. The distance between the 
anus and the genital organ is 
greater than in the female indicated 
by the black arrows. A prominent 
crease is readily apparent in the 
perineum indicated by the short 
arrow.
Figure 6 Female external genitalia
1
Figure 6
External genitalia of a 21dpc female 
rat fetus. The black arrows show the 
shorter distance between the anus 
and the genital organ compared to 
the male
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Internal Genitalia of Male and Female 21dpc Rat Fetus
Figure 7 Male internal genitalia.
Figure 7
Internal genitalia of a male 
21dpc rat fetus. The testes 
in the male are 
undescended at this stage 
indicated by the black 
arrows.
Figure 8 Female internal genitalia
Figure 8
Internal genitalia of a 
female 21dpc rat fetus. The 
horns of the bicornuate 
female uterus and the 
ovaries are indicated by 
the black arrows
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3.4 Diaphragm Images from Non Nitrofen Exposed (Control) and Nitrofen 
Exposed 21dpc (Without a Hernia) Rat Fetuses 
Below is a series of images of the typical diaphragm findings 
Figure 9 Control (non nitrofen exposed diaphragm)
Figure 9
Diaphragm from a 21dpc 
non nitrofen exposed rat 
fetus. This shows a well 
muscularised diaphragm. 
The arrow indicates the 
position of the spine
The black arrow indicates the position of the spine in this figure and all 
subsequent diaphragmatic figures are in the same orientation
Figure 10 Diaphragm from a nitrofen exposed fetus without a hernia
Figure 10
Diaphragm from 21dpc 
nitrofen exposed fetus 
without a hernia. The 
diaphragm is thinner than 
that of the control and the 
outline of the lungs are 
readily visible through it as 
marked by the black 
arrows. The diaphragm 
was also domed protuding 
into the area of the 
thoracic cavity, an 
eventration of the 
diaphragm
In the following figures of congenital diaphragmatic hernias the thickened rim of 
muscle surrounding the hernia can be seen.
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Figure 11 Diaphragm showing left sided congenital diaphragmatic hernia
*
Figure 11
Diaphragm from 21dpc 
nitrofen exposed fetus 
showing a left sided 
congenital diaphragmatic 
hernia. The ribs can be 
seen through the 
diaphragmatic defect in the 
area of the thoracic cavity 
from which abdominal 
organs have been removed
Figure 12 Diaphragm showing right sided congenital diaphragmatic hernia
Figure 12
Diaphragm from a 21dpc 
nitrofen exposed fetus 
showing a right sided 
congenital diaphragmatic 
hernia. The ribs of the 
thoracic cavity can also be 
clearly seen through the 
hernia from where 
abdominal organs were 
extracted.
Figure 13 Diaphragm showing bilateral congenital diaphragmatic hernias
Figure 13
Diaphragm from a 21dpc 
nitrofen exposed fetus 
showing bilateral 
congenital diaphragmatic 
hernias. The ribs of the 
thoracic cavity can be seen 
through the hernias and 
the hypoplastic lung can 
be seen high in the 
thoracic cavity through the 
left sided hernia, marked 
by a black arrow.
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Figure 14
Gender and results of examination for CDH from Excel spreadsheet 
Male = M Female = F
M M M M M F F F F F
Dam
no.
No
CDH
L
CDH
R
CDH
Bil
CDH Total
No
CDH CDH
R
CDH
Bil
CDH Total
1 2 5 0 0 7 3 3 0 2 8
2 7 1 2 0 10 3 1 2 0 6
3 10 1 3 0 14 3 0 0 0 3
4 1 1 0 0 2 2 0 0 0 2
5 2 2 0 1 5 2 4 0 0 6
6 2 2 1 0 5 4 0 2 0 6
7 3 5 1 0 9 3 3 1 0 7
8 4 3 2 0 9 1 2 2 1 6
9 2 1 0 0 3 1 0 0 0 1
10 1 3 1 0 5 0 10 0 0 10
11 2 0 0 3 5 0 1 1 0 2
12 6 2 0 0 8 4 2 0 0 6
13 1 4 0 0 5 2 9 0 0 11
14 5 1 0 0 6 8 2 3 0 13
15 5 1 0 0 6 4 1 0 0 5
16 2 2 0 0 4 7 2 0 0 9
17 3 0 1 0 4 5 3 1 0 9
18 1 4 0 0 5 2 6 0 2 10
19 2 4 1 0 7 2 4 0 0 6
20 5 1 2 0 8 3 0 2 0 5
21 5 1 0 2 8 2 2 1 0 5
22 4 2 0 0 6 0 5 0 0 5
23 3 0 3 0 6 6 0 0 0 6
24 2 1 0 0 3 8 0 0 0 8
25 4 1 0 0 5 7 1 1 0 9
26 3 6 0 0 9 1 4 0 0 5
27 7 1 0 0 8 0 6 0 1 7
28 4 0 2 0 6 4 1 2 0 7
29 8 1 0 0 9 4 1 0 0 5
30 8 4 0 0 12 2 3 0 0 5
31 4 7 0 0 11 1 6 0 0 7
32 5 1 1 0 7 4 0 1 0 5
33 3 1 0 0 4 4 4 2 0 10
34 1 4 0 1 6 7 5 0 0 12
35 6 6 0 0 12 0 2 0 0 2
36 4 0 1 0 5 8 1 0 0 9
37 1 3 0 0 4 2 8 0 0 10
38 2 2 0 0 4 2 2 0 0 4
39 4 3 0 1 8 3 3 0 0 6
Totals 144 87 21 8 260 124 107 21 6 258
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Table 1
Table showing numbers of male and female nitrofen exposed offspring with 
and without CDH
Male Female TOTALS
No CDH 144 124 268
Left CDH 87 107 194
Right CDH 21 21 42
Bilateral CDH 8 6 14
TOTALS 260 258 518
Table 2
Table showing proportion (as percentages) of nitrofen exposed offspring with 
and without CDH
Male Female
No CDH 55.3% 48.1%
Left CDH 33.5% 41.5%
Right CDH 8.1% 8.1%
Bilateral CDH 3.1% 2.3%
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Table 3
Table showing the number of cases of CDH (as a total) in nitrofen exposed 
offspring
Male Female TOTAL
No CDH 144 124 268
CDH 116 134 250
TOTAL 260 258 518
Figure 15
Graph showing CDH distribution as a percentage in nitrofen exposed 
offspring
HERNIA DISTRIBUTION
601
No CDH L-CDH R-CDH B-CDH
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Although there were more cases of congenital diaphragmatic hernia in the female 
offspring of nitrofen exposed dams this was not found to be significant. Chi squared 
test was performed to ascertain the significance of the results p=0.113.
An odds ratio was also calculated. The odds of a male rat fetus having a congenital 
diaphragmatic hernia is 0.75 of a female rat fetus. The confidence intervals 
recorded were 0.53 - 1.06. The confidence intervals span 1.0 thus indicating non­
significance.
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CHAPTER 4
Is There a Gender Susceptibility to Congenital Diaphragmatic 
Hernia in the Nitrofen Model of Congenital Diaphragmatic 
Hernia and does it have Disorders of Sexual Development? 
Discussion and Conclusions
Human congenital diaphragmatic hernia is frequently encountered with multiple co­
existing anomalies, including cardiac, renal, skeletal, respiratory and genital tract 
anomalies (Sweed and Puri 1993; Fauza and Wilson 1994; Losty, Vanamo et al. 
1998). Environmental agents are implicated in the aetiology of human 
malformations. Evidence from animal models suggest that it is a malformation of the 
mesenchymal substratum and the pleuroperitoneal fold that underlies the defect in 
the mature diaphragm and there is indirect evidence to suggest that this may also 
apply in human cases of Bochdalek congenital diaphragmatic hernia (Greer, Cote et 
al. 2000). Congenital diaphragmatic hernia can be produced experimentally in the 
offspring of nitrofen exposed rodents. Greer and colleagues have demonstrated that 
nitrofen interferes with retinoic acid signaling (Noble, Babiuk et al. 2007). Moreover, 
human infants with congenital diaphragmatic hernia have been demonstrated to 
have reduced levels of retinol binding protein (Beurskens, Tibboel et al. 2010). 
Retinoid signaling links with steroidogenesis and may influence downstream sexual 
differentiation pathway^. This study tested the hypothesis that there may be gender 
susceptibility to nitrofen exposure and that intersex states may be present in the 
nitrofen model of congenital diaphragmatic hernia.
Congenital diaphragmatic hernia is a life threatening condition affecting 
approximately 1 in 3000 live births with a high mortality. It can be classed as 
isolated or complex and disorders of sex development can often accompany 
congenital diaphragmatic hernia. Currently congenital diaphragmatic hernia is 
considered to be found more frequent in human males (Robert, Kallen et al. 1997; 
Lisi, Botto et al. 2005) but historically the gender distribution reports have been 
ambiguous (David and Illingworth 1976; David 1980; David, Parker et al. 1980).
Although the results are not significant in this study more cases of congenital 
diaphragmatic were found in the female fetal rat population. The human studies 
concerning gender and the distribution of congenital diaphragmatic hernia included 
all cases whatever the causative mechanism may have been. In the rat model of
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congenital diaphragmatic hernia normal embryological development occurs until the 
time of dosing with nitrofen at 9.5dpc. This would lead to a supposition that this 
model is more applicable to the human condition where the congenital 
diaphragmatic hernia may have been caused by environmental factors.
Disorders of sex development affect approximately 1 in 1000 live births and 1 in 
4600 have ambiguous genitalia (Gillam, Hewitt et al. 2010). Disorders of sex 
development cause considerable problems to the patient, the patient’s family and 
the clinical team deciding the best course for the long term welfare of the patient 
(Gillam, Hewitt et al. 2010; Gillam, Hewitt et al. 2011).
In both congenital diaphragmatic hernia and disorders of sex development, many 
cases have no known cause and also in some recognised syndromes including both 
of these anomalies amongst their features the causative agent is still unidentified. 
Research is continually adding to our understanding of these problems as shown by 
a recently published case concerning a mutation in a previously unidentified 
alternative pathway of dihydrotestosterone production. This mutation has been 
identified in a family and is the first case of this alternative pathway to be discovered 
in the human population, previously this pathway had only been identified in a 
marsupial (Fluck, Meyer-Boni etal. 2011).
4.1 Role of Animal Models in Understanding Organ Development
The advent of knock in, knock out and teratogenic animal models has greatly 
increased our understanding of the development of the embryo. These have 
enabled us to understand the relationship and interactions between genes, 
transcription factors, proteins and various pathways during development. The 
expression patterns of these factors is well preserved between species including 
invertebrates although the timing of the mechanisms involved may differ slightly 
(Ghabrial, Luschnig et al. 2003). Many mutant animal models have congenital 
diaphragmatic hernia, pulmonary hypoplasia and pulmonary hypertension combined 
with disorders of sex development allowing for a cautious translation of the role of 
these factors to the embryological development of these problems in the human 
population.
Disruption in the development of the mesenchyme, 'the mesenchymal hit 
hypothesis’, is one mechanism describing the embryopathy of diaphragmatic and 
extradiaphragmatic defects including disorders of sex development. Signalling 
pathways are similar in ail the affected organs and environmental or genetic factors
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may cause a perturbation of these pathways disrupting the function of the 
mesenchymal cells (Keijzer, Liu et al. 2000; Featherstone, Connell et al. 2006; 
Jesudason 2006; Jesudason, Smith et al. 2006).
Germline mutations in transcription factors may lead to impaired structural integrity 
and development of the affected organs. Several factors have been identified that 
have a multi organ developmental role including WT1, FGF9, The retinoic acid 
pathway, FGFR2, FGF10, FOG2 and GATA4, (Lin, Tsai et al. 2010).
One of the bhlh transcription factors capsulin (pod1) has been identified as causing 
congenital diaphragmatic hernia, disorders of sex development and other anomalies 
in mice but as yet no human cases have been identified (Lu, Chang et al. 2000; Lu, 
Bassel-Duby et al. 2002; Cui, Ross et al. 2004).
4.2 The Nitrofen Rat Model
The nitrofen rat model shows disruption in the expression of many of the factors 
involved in multi organ development. Given below are the factors involved 
particularly with the development of the diaphragm, lungs and the reproductive 
systems and the recognised syndromes including these anomalies.
Nitrofen suppresses the action of retinaldehyde dehydrogenase-2, the key enzyme 
involved in retinoic acid production (Greer, Cote et al. 2000; Greer, Babiuk et al. 
2003).
Wilms tumour gene 1 (WT1) expression is reduced in nitrofen exposed rat foetuses. 
Mutations in WT1 cause a range of overlapping clinical syndromes, Denys Drash, 
Frazier, WAGR and Meacham syndromes all of which may have clinical features of 
disorders of sex development and congenital diaphragmatic hernia. WT1 is 
expressed in the amuscular diaphragm, pleural and abdominal mesothelial cells, the 
epicardium , testicular somatic cells and the developing kidney (Kreidberg, Sarioia 
et al. 1993; Moore, Mclnnes et al. 1999; Natoli, Alberta et al. 2004).
Fryns syndrome is the most common multiple congenital anomaly syndrome 
associated with congenital diaphragmatic hernia although at present its cause is 
unknown (Slavotinek 2004; Gremeau, Coste et al. 2009). Acosta and colleagues 
created a Fryns syndrome type anomaly in a mouse by the administration of 
nitrofen. Although many of the anomalies present were typical of those caused by 
nitrofen administration and resembled some clinical features of Fryns syndrome no 
mention was made of disorders of sex development (Acosta, Chai et al. 2001).
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Several genes associated with the retinoic acid pathway including Chicken 
ovalbumin upstream promoter-transcription factor 11 (COUP-TF11), GATA binding 
protein 4 (GATA4) and friend of GATA 2 (FOG2.) are all located on a chromosomal 
‘hot spot’ for congenital diaphragmatic hernia. It is speculated that the expression of 
these factors is altered after nitrofen exposure disrupting downstream genes in lung 
and diaphragm development (Doi, Sugimoto et al. 2009). The pulmonary gene 
expression of coup~tf11 is upregulated in the early stages of development, 9.5dpc to 
15dpc of the nitrofen induced hypoplastic rat lung and this increased expression of 
coup-tf11 may inhibit the retinoid signaling pathway (Doi, Sugimoto et al. 2009). 
Also treating pregnant nitrofen exposed rats with retinoic acid upregulates the 
pulmonary gene expression of coup-tfH, GATA4, and fog2 in the offspring, (Doi, 
Sugimoto et al. 2009). The interactions and expressions of GATA4 and FOG2 are 
present in the early gonads of both sexes and mark the developing somatic cell 
lineage, Sertoli cells in the XY gonad and the granulosa cells in the XX gonad 
(Biason-Lauber 2010).
4.3 Nitrofen and Disorders of Sex Development
There are no references in the literature of nitrofen causing disorders of sex 
development. The only reference to nitrofen administration and internal and external 
sexual phenotype is this study (Connell, Corbett et al. 2006). However in this study 
only gross sexual phenotype was studied and possibly minor disturbances of sexual 
development may not have been detected, or that a study comprising larger 
numbers may have revealed some disorders of sex development. This study 
involved the administering of nitrofen at a specific time, 9.5dpc, and concentration, 
100mg to cause predominantly left sided congenital diaphragmatic hernia. 
Therefore it cannot be assumed that nitrofen exposure at a different time or 
concentration would not produce disorders of sex development. Nitrofen perturbs 
factors involved in sex development and these factors may be expressed at a 
different time in sex development. The concentration of nitrofen in the embryo may 
be insufficient to interfere with sex development although it has been reported to 
affect renal development (Chertin, Nakazawa et al. 2006; Montedonico, Nakazawa 
et al. 2007).
4.4 Conclusions
From the paper published and presentation from this study, congenital 
diaphragmatic hernia was encountered with equal incidence in male and female
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offspring using the current nitrofen dosing schedule. In conclusion, as reported in 
the paper, there is no sex risk for nitrofen induced congenital diaphragmatic hernia 
unlike conflicting human data (p=0.085) (Connell, Corbett et al. 2006). This thesis 
with increased numbers to the original publication also has no significant sex risk for 
nitrofen induced congenital diaphragmatic hernia (p=.113). This raises the 
possibility of a type 2 error, (i.e. if the numbers were increased a significant 
difference may be apparent). As this study could be considered to be more 
applicable to environmental causative agents it may be speculated that this may 
have a bearing on the difference in sex risk for congenital diaphragmatic hernia 
between this rat model and the human data. This may reflect the nature of this 
model, in that the offspring have no greater susceptibility prior to exposure with 
nitrofen.
The nitrofen litters did not show evidence of excessive prenatal resorptions of one 
sex or the other, (i.e. hidden mortality) as the ratio of males to females in the 
nitrofen exposed litters equalled the male to female ratio in the control population.
It is interesting to reflect on the possible mechanisms for no significant difference in 
the incidence of left congenital diaphragmatic hernia in the nitrofen exposed 
offspring especially when recent data from a number of human studies suggest an 
increased incidence in males (David and Illingworth 1976; David, Parker et al. 1980; 
Robert, Kallen et al. 1997; Lisi, Botto et al. 2005).
No evidence of gross morphological disorders of sex development were 
encountered in this study however minor disorders may have been present 
undetectable by the methods involved. The fertility of the offspring could not be 
assessed under the terms of the licence.
4.5 Future Work
This study looked at the relationship of congenital diaphragmatic hernia with 
disorders of sex development in the nitrofen rat model of predominantly left sided 
hernia produced by a specific dosing schedule of nitrofen at 9.5dpc. To create 
predominately right sided congenital diaphragmatic hernia dosing is carried out at 
11.5dpc (Kluth, Kangah et al. 1990). A study using this dosing protocol to create 
predominantly right sided congenital diaphragmatic hernia was started and fetuses 
examined for diaphragmatic defects, gender and internal and external genitalia. This 
study was incomplete and insufficient data were obtained to draw conclusions. To
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add to these numbers and check for disorders of sex development would complete 
this study.
To ascertain if nitrofen had an effect on sex development a timed series of dosing 
schedules with different concentrations of nitrofen would be required. A more 
detailed study of the internal and external genitalia than the gross morphology used 
in this study would be useful. Chromosomal analysis would improve the validity of 
sex determination.
Disorders of sex development and congenital diaphragmatic hernia with associated 
pulmonary problems cause considerable lifelong morbidity. These conditions place 
a drain on health resources. As understanding of developmental biology increases, 
so the mechanisms that underpin these processes will become more apparent. 
This thesis highlights potential linkage between certain developmental pathways, 
explaining to some degree co-morbidities and further research will hopefully clarify 
these relationships.
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Abstract Background and purpose: Human studies note 
sex reversal syndromes and sex difference(s) in the 
incidence of congenital diaphragmatic hernia (CDH). 
Epidemiology surveys record a higher incidence of 
CDH in females, whilst other reports cite a higher fre­
quency in males. Nitrofen, a teratogen, produces 
experimental CDH. This agent is speculated to interfere 
with retinoid acid-steroid signalling pathways and may 
also be linked with sexual differentiation. This study 
was designed therefore to test the hypothesis that ni­
trofen may influence sexual phenotype and frequency of 
CDH. Methods: Time mated Sprague Dawley rats were 
dosed with nitrofen at day 9.5 to generate predomi­
nantly left sided CDH. Fetuses were delivered by cae­
sarean section on days 20 or 21 of gestation (term = day 
22). External genitalia were examined to define external 
genital phenotype. The abdominal cavity was opened 
and the genito-urinary system carefully examined. The 
internal genital organs were assigned a phenotype and 
findings correlated with external appearances. The dia­
phragm of each fetus was studied for the absence or 
presence of CDH and the laterality of defect recorded. 
Controls (non nitrofen fed) were used for all compara­
tive analysis. Results: Control (a = 600) and nitrofen 
exposed offspring (« = 504) had equal frequencies of 
males and females. CDH occurred with similar inci­
dence in male and female nitrofen treated pups. In all 
nitrofen exposed fetuses and normal controls, internal 
and external genitalia concorded without evidence of 
significant genital tract malformations or intersex states. 
Conclusions: Prenatal nitrofen exposure is not associ­
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ated with significant gender differences (or prenatal loss) 
in the risk of CDH. Genital tract malformations do not 
appear to accompany CDH in the nitrofen model.
Keywords Sexual phenotype • Congenital 
diaphragmatic hernia • Nitrofen
Introduction
Congenital diaphragmatic hernia (CDH) is a birth defect 
affecting one in 3,000 live births with high mortality. 
Since 1971, nitrofen, an herbicide teratogen with 
homology to thyroid hormone, has been known to in­
duce multiple abnormalities in rodents [1]. These include 
cardiac, renal, central nervous system, gastrointestinal, 
lung hypoplasia and CDH. Nitrofen dosing at varying 
gestational time schedules (e.g. days 9.5 and 10.5) yields a 
spectrum of malformations and diaphragmatic defects 
[2]. Studies have recently shown that nitrofen interferes 
with retinoid acid signalling [3-6]. This pathway links 
with steroidogenesis and may perturb sexual differenti­
ation and phenotype. Whilst the cause of sporadic (non 
familial) CDH is unknown, it is of interest that sex 
reversal states (e.g. Meacham’s and Swyer’s syndrome) 
are reported with CDH [7, 8] Epidemiology surveys and 
human population registries note conflicting data on 
CDH and sex. Some early reports suggest a female pre­
dominance [9, 10] but latterly CDH has been cited as 
being more common in males [11, 12]. Is there gender 
susceptibility to CDH? This study was designed to 
examine whether nitrofen administration influences 
gender prevalence of experimental CDH and intersex 
anomaly states.
Materials and methods
Sprague Dawley rats (Charles River UK Ltd) were 
time-mated to generate offspring. Pregnant dams were 
gavage fed 100 mg Nitrofen (Zhejiang Chemicals,
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Fig. 1 External genitalia of a 21 days male (a) and female (b) rat 
fetus. Note the male has a greater distance between the base of the 
genitalia and the anal orifice versus female. A prominent skin 
crease is readily apparent in the male perineum
Fig. 2 Appearance of the internal genitalia of a 21 days male (a) 
and female (b) rat fetus. The testes in the male are undescended at 
this stage. The horns of the bicornuate female uterus are apparent. 
The ovaries are adjacent to the uterus/tubes
Peoples Republic of China) dissolved in 2 ml of olive 
oil on gestation day 9.5 to induce predominately left 
sided CDH (LCDH)—Term = day 22.5. Controls (non 
nitrofen fed) were utilised for all comparative analysis. 
Euthanised fetuses were recovered by elective caesar­
ean section on days 20 and 21. The external genitalia 
of each pup was examined to determine sexual phe­
notype (Fig. 1). The abdomen was opened and the 
liver and gastro-intestinal tract carefully removed to 
reveal the internal genito-urinary system and the dia­
phragm. Internal genitalia were examined for the 
presence/absence of testes, ovaries and uterus with 
fallopian tubes (Fig. 2). Findings were correlated with 
external genitalia for intersex anomalies. The site and 
position of CDH was recorded (Figs. 3, 4). Fixed 
specimens (10% buffered formalin) were archived for 
clinical photography. All procedures were performed 
in accordance with the UK Home Office legislation 
and regulations.
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Fig. 3 Normal intact diaphragm (term control) viewed on cross 
section
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Fig. 4 Diaphragm anomalies 
from a selection of nitrofen 
exposed term rat fetuses. Panels 
demonstrate (a) Left CDH, (b) 
Right CDH, (c) Bilateral CDH 
and (d) Non-CDH
M'm
Results
Controls (« = 600) and nitrofen exposed pups (« = 504) 
had equal frequencies of males and females. CDH 
occurred with a similar incidence in male and female 
nitrofen treated pups. In all nitrofen exposed fetuses and 
normal controls, internal and external genitalia con- 
corded without evidence of significant genital tract 
malformations or intersex states Findings are summar­
ised in Fig. 5. There was no evidence of excess fetal loss 
(i.e. prenatal resorptions) in either sex after nitrofen 
exposure as the ratios of male: female pups matched the 
control birth population.
Discussion
Human CDH is frequently encountered with multiple 
co-existent anomalies indicating a major disturbance in 
embryological development [13-15]. The aetiology of 
this lethal birth defect remains largely unknown. Chro­
mosomal defects and genetic disorders are reported 
whilst rare sex reversal states (e.g. Meacham’s and 
Swyer’s syndrome) [7, 8] are also noted in CDH. Birth 
registries and epidemiology surveys record conflicting 
data on gender and CDH with early reports from the 
1960’s suggesting female predominance. Later studies 
challenge these findings [9-12].
Environmental agents are implicated in the aetiology 
of human malformations. CDH can be produced 
experimentally in timed pregnant rodents with the her­
bicide nitrofen. Greer and colleagues have recently 
demonstrated that nitrofen interferes with retinoid acid 
signalling. Moreover, human infants with CDH have
been demonstrated to have reduced levels of retinol 
binding protein [3-6]. Retinoid signalling links with 
steroidogenesis and may influence downstream sexual 
differentiation pathways. We therefore tested the 
hypothesis that there may be gender susceptibility and 
intersex states in the nitrofen CDH model.
Our findings demonstrate no sex at greater risk for 
CDH. Exposure to the teratogen—nitrofen at the
601
No CDH L-CDH R-CDH B-CDH
Fig. 5 Diaphragm anomalies (expressed as a percentage) in 
nitrofen exposed fetuses. There are no significant differences in 
incidence males versus females (Chi-square)
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indifferent sexual stage (day 9.5) in the developing rat 
embryo does not perturb gross sexual differentiation. 
Intersex anomalies such as those encountered in humans 
(Meacham’s, Swyer’s syndrome) [7, 8] were not readily 
detected. Furthermore, nitrofen exposed litters did not 
show evidence of excessive prenatal resorptions in one 
sex or other (i.e. ‘hidden mortality’) [16]. CDH was 
encountered with equal incidence in male and female 
offspring using the current nitrofen dosing schedule. In 
conclusion, it appears from this experimental study that 
there is no sex risk for nitrofen-induced CDH (unlike 
conflicting human data).
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